<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Parkinson's on VitaminDWiki</title><link>/categories/parkinsons.html</link><description>Recent content in Parkinson's on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 05 May 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/parkinsons/index.xml" rel="self" type="application/rss+xml"/><item><title>Glutathione fights Parkinson's Disease</title><link>/posts/glutathione-fights-parkinsons-disease.html</link><pubDate>Sun, 05 May 2024 00:00:00 +0000</pubDate><guid>/posts/glutathione-fights-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#from-perplexity-ai---may-2024">From Perplexity AI - May 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="from-perplexity-ai---may-2024">From Perplexity AI - May 2024&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.perplexity.ai/search/Does-Glutathione-help-WxnpFjeqQquCoLBY8kJQcQ">14 references&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Glutathione, a naturally occurring antioxidant, has been extensively studied for its potential benefits in treating Parkinson&amp;rsquo;s Disease (PD), a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. The research on glutathione&amp;rsquo;s effectiveness in PD treatment presents a complex picture, with studies indicating both potential benefits and limitations.&lt;/p>
&lt;h5 id="role-of-glutathione-in-parkinsons-disease">Role of Glutathione in Parkinson&amp;rsquo;s Disease&lt;/h5>
&lt;p>Glutathione plays a crucial role in protecting cells from oxidative stress, which is a significant factor in the pathogenesis of PD. In PD patients, glutathione levels are notably lower in the brain, particularly in the substantia nigra, the region most affected by the disease &lt;a href="https://www.michaeljfox.org/news/ask-md-glutathione-and-parkinsons">7&lt;/a>. This deficiency is linked to increased oxidative stress and neuronal damage &lt;a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395390/">8&lt;/a>.&lt;/p></description></item><item><title>Risk of Parkinson’s decreases with time in summer sun</title><link>/posts/risk-of-parkinsons-decreases-with-time-in-summer-sun.html</link><pubDate>Thu, 04 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/risk-of-parkinsons-decreases-with-time-in-summer-sun.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-of-time-spent-outdoors-with-the-risk-of-parkinsons-disease-a-prospective-cohort-study-of-329359-participants">Association of time spent outdoors with the risk of Parkinson&amp;rsquo;s disease: a prospective cohort study of 329,359 participants&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-of-time-spent-outdoors-with-the-risk-of-parkinsons-disease-a-prospective-cohort-study-of-329359-participants">Association of time spent outdoors with the risk of Parkinson&amp;rsquo;s disease: a prospective cohort study of 329,359 participants&lt;/h4>
&lt;p>BMC Neurol. 2024 Jan 2;24(1):10. &lt;a href="https://doi.org/10.1186/s12883-023-03499-7.">doi: 10.1186/s12883-023-03499-7.&lt;/a>&lt;/p>
&lt;p>Ling Hu # 1, Yisen Shi # 2 3, Xinyang Zou 2 3, Zhaohui Lai 1, Fabin Lin 4, Guoen Cai 5, Xianghong Liu 6&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/pd-outdoors.png" alt="image" width="400">
&lt;p>16% reduced risk if outdoors for &amp;gt; 5 hrs&lt;/p></description></item><item><title>Central Nervous System protection by Vitamin D</title><link>/posts/central-nervous-system-protection-by-vitamin-d.html</link><pubDate>Thu, 21 Dec 2023 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-protection-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#molecular-regulation-of-the-cns-by-vitamin-d">Molecular Regulation of the CNS by Vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="molecular-regulation-of-the-cns-by-vitamin-d">Molecular Regulation of the CNS by Vitamin D&lt;/h4>
&lt;p>Physiol Res 2023 Dec 17;72(S4):S339-S356.&lt;/p>
&lt;p>L Máčová 1, R Kancheva, M Bičíková&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/cns-d.png" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/neuroprotective-d.png" alt="image" width="800">
&lt;p>&lt;strong>&lt;span style="color:#096;">Factors that are up-regulated are marked in green&lt;/span>&lt;br>
&lt;span style="color:#F06;">factors that are down-regulated are in red&lt;/span>.&lt;/strong>&lt;/p>
&lt;p>Vitamin D is a lipid-soluble vitamin that can be found in some foods. It is also produced endogenously (in the presence of ultraviolet light), transported through the blood to the targets organs and this is the reason to consider vitamin D as a hormone. It is known that vitamin D has genomic and non-genomic effects.&lt;/p></description></item><item><title>Many Neurological Diseases fought by Vitamin D</title><link>/posts/many-neurological-diseases-fought-by-vitamin-d.html</link><pubDate>Thu, 26 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/many-neurological-diseases-fought-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-in-neurological-diseases">Vitamin D in Neurological Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#315-clinical-trials-of-neurological-diseases-and-vitamin-d---oct-2023">315 clinical trials of neurological diseases and Vitamin D - Oct 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-in-neurological-diseases">Vitamin D in Neurological Diseases&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2023, 24(1), 87; &lt;a href="https://doi.org/10.3390/ijms24010087">https://doi.org/10.3390/ijms24010087&lt;/a>&lt;/p>
&lt;p>by Domenico Plantone 1,*ORCID,Guido Primiano 2,3ORCID,Carlo Manco 1,Sara Locci 1,Serenella Servidei 2,3ORCID andNicola De Stefano 1&lt;/p>
&lt;p>1 Centre for Precision and Translational Medicine, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy&lt;/p>
&lt;p>2 Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy&lt;/p></description></item><item><title>Parkinson’s disease: Review of low-dose vitamin D RCTs found small benefit</title><link>/posts/parkinsons-disease-review-of-low-dose-vitamin-d-rcts-found-small-benefit.html</link><pubDate>Fri, 06 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-review-of-low-dose-vitamin-d-rcts-found-small-benefit.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-in-parkinsons-disease-a-systematic-review-of-randomized-controlled-trials">Vitamin D in Parkinson’s disease: A systematic review of randomized controlled trials.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-in-parkinsons-disease-a-systematic-review-of-randomized-controlled-trials">Vitamin D in Parkinson’s disease: A systematic review of randomized controlled trials.&lt;/h4>
&lt;p>Clinical Nutrition Open Science Available online 28 September 2023 &lt;a href="https://doi.org/10.1016/j.nutos.2023.09.005">https://doi.org/10.1016/j.nutos.2023.09.005&lt;/a>&lt;/p>
&lt;p>Paraskevi Detopoulou 1 3, Gavriela Voulgaridou 2, Alexandra Saridaki 1 3, Ioanna Pylarinou 3, Elissaios- Minos Argyris 1, Vasilios Dedes 3, Constantinos Giaginis 4, Georgios I. Panoutsopoulos 3, Sousana K. Papadopoulou 2&lt;/p>
&lt;p>In recent years, neurodegenerative diseases are a leading cause of morbidity and disability worldwide, with Parkinson&amp;rsquo;s disease (PD) being the most prevalent. Although diet and vitamin status play a crucial role in PD, the results of vitamin D supplementation are scarce and contradictory. Therefore, the present systematic work reviewed the available randomized controlled trials (RCTs) regarding the role of vitamin D supplementation in patients with PD in the Pubmed, Scopus and Cochrane databases and in grey literature. Four RCTs including 321 patients with PD were identified. Various doses of vitamin D were administered &lt;strong>(1,000- 10,000 IU/d)&lt;/strong> and different exposure outcomes were assessed. One study reported beneficial effects of vitamin D on the Hoehn and Yahr scale (HY) and two studies reported null effects on the Unified Parkinson&amp;rsquo;s Disease Rating Scale (UPDRS). Regarding functional tests, heterogeneous results in the timed-up and go (TUG) test were observed in two studies. One study conducted minute walking tests at 6 and 10 minutes and found an improvement only in the 6MWT. In conclusion, a very small number of RCTs have assessed the effects of vitamin D supplementation on PD. Some isolated beneficial effects of vitamin D were reported on functional scales and tests but more studies are needed to draw safe conclusions regarding its supplementation in PD.&lt;/p></description></item><item><title>Parkinson's disease prevented by Vitamin D, but small doses do not treat it</title><link>/posts/parkinsons-disease-prevented-by-vitamin-d-but-small-doses-do-not-treat-it.html</link><pubDate>Wed, 09 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-prevented-by-vitamin-d-but-small-doses-do-not-treat-it.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#does-vitamin-d-protect-or-treat-parkinsons-disease-a-narrative-review">Does vitamin D protect or treat Parkinson&amp;rsquo;s disease? A narrative review&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="does-vitamin-d-protect-or-treat-parkinsons-disease-a-narrative-review">Does vitamin D protect or treat Parkinson&amp;rsquo;s disease? A narrative review&lt;/h4>
&lt;p>Naunyn Schmiedebergs Arch Pharmacol 2023 Aug 9.DOI: 10.1007/s00210-023-02656-6&lt;/p>
&lt;p>Hayder M Al-Kuraishy 1, Ali I Al-Gareeb 1, Hend Mostafa Selim 2, Athanasios Alexiou 3 4, Marios Papadakis 5, Walaa A Negm 6, Gaber El-Saber Batiha 7&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/biological-effects.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/brain.jpg" alt="image" width="800">
&lt;p>Parkinson&amp;rsquo;s disease (PD) is a neurodegenerative brain disease (NBD) developed due to dopaminergic neuron loss in the substantia nigra (SN). Vitamin D (VD), VD receptor (VDR), and VD metabolites are highly expressed in the human brain and play a critical role in maintaining different brain functions. VDRs are highly expressed in the SN that regulates the activity of dopaminergic neurons and synaptic plasticity. VD exerts protective and therapeutic effects against the development of PD by modulating dopaminergic neurons of SN. VD reduces oxidative stress and neuroinflammation in PD because of its anti-inflammatory and antioxidant activities. Different studies revealed the protective effect of VD in the management of PD. However, the potential therapeutic effect of VD in well-established PD remains controversial. Therefore, this review aims to elucidate VD&amp;rsquo;s preventive and therapeutic roles in PD.&lt;/p></description></item><item><title>Global burden of brain disorders surpasses cardiovascular disease and cancer</title><link>/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer.html</link><pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#from-mdedgehttpswwwmdedgecomneurologyarticle264086neurologyglobal-burden-brain-disorders-surpasses-cardiovascular-diseaseecdwnl_eve_230715_mdedge">From &lt;a href="https://www.mdedge.com/neurology/article/264086/neurology/global-burden-brain-disorders-surpasses-cardiovascular-disease?ecd=WNL_EVE_230715_mdedge">MDEdge&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-inhaled-thru-the-nose-gets-some-directly-to-the-brain">Vitamin D inhaled thru the nose gets some directly to the brain&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="from-mdedgehttpswwwmdedgecomneurologyarticle264086neurologyglobal-burden-brain-disorders-surpasses-cardiovascular-diseaseecdwnl_eve_230715_mdedge">From &lt;a href="https://www.mdedge.com/neurology/article/264086/neurology/global-burden-brain-disorders-surpasses-cardiovascular-disease?ecd=WNL_EVE_230715_mdedge">MDEdge&lt;/a>&lt;/h4>
&lt;p>Brain disorders, including mental illness, neurologic conditions, and stroke, account for more than 15% of all health loss worldwide – more than either cardiovascular disease or cancer – at huge cost to health care systems and society, an analysis of data from the most recent Global Burden of Disease (GBD) study shows.&lt;/p>
&lt;p>“The burden of brain conditions will increase as populations continue to grow and age,” said study presenter Shayla Smith, MPH, an epidemiologist at the Institute for Health Metrics and Evaluation, the University of Washington, Seattle, in a press release.&lt;/p></description></item><item><title>Parkinson’s – Vitamin D, bone and falls</title><link>/posts/parkinsons-vitamin-d-bone-and-falls.html</link><pubDate>Wed, 10 May 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-vitamin-d-bone-and-falls.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-relationship-among-bone-mineral-density-bone-biomarkers-and-vitamin-d-levels-in-patients-with-parkinsons-disease">The Relationship Among Bone Mineral Density, Bone Biomarkers and Vitamin D Levels in Patients with Parkinson&amp;rsquo;s Disease.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-relationship-among-bone-mineral-density-bone-biomarkers-and-vitamin-d-levels-in-patients-with-parkinsons-disease">The Relationship Among Bone Mineral Density, Bone Biomarkers and Vitamin D Levels in Patients with Parkinson&amp;rsquo;s Disease.&lt;/h4>
&lt;p>Clinical Laboratory, 01 Aug 2020, 66(8) DOI: 10.7754/clin.lab.2019.190615 PDF is behind a paywall&lt;/p>
&lt;p>Can NU, Alagöz AN&lt;/p>
&lt;p>&lt;strong>Idiopathic Parkinson&amp;rsquo;s disease (IPD)&lt;/strong> is the most common age-related neurodegenerative movement disorder. It causes a decrease and deceleration in movements. It may also lead to loss of bone mineral density, vitamin D deficiency, falls and fractures due to various factors. As indicated in our study, determining the prevalence of osteopenia and osteoporosis in IPD is important to determine complications.&lt;/p></description></item><item><title>Parkinson’s Disease and Vitamin D – review of 52 studies</title><link>/posts/parkinsons-disease-and-vitamin-d-review-of-52-studies.html</link><pubDate>Wed, 10 May 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-vitamin-d-review-of-52-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-parkinsons-disease">Vitamin D and Parkinson’s Disease&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-parkinsons-disease">Vitamin D and Parkinson’s Disease&lt;/h4>
&lt;p>Nutrients Volume 14 Issue 6 10.3390/nu14061220&lt;/p>
&lt;p>Antonia Pignolo 1ORCID,Sergio Mastrilli 1,Chiara Davì 1ORCID,Valentina Arnao 2,Paolo Aridon 1,Felipe Augusto dos Santos Mendes 3ORCID,Cesare Gagliardo 1ORCID andMarco D’Amelio 1,*&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2 UO Neurologia e Stroke Unit, Azienda di Rilievo Nazionale ad Alta Specializzazione, Ospedali Civico Di Cristina Benfratelli, 90134 Palermo, Italy&lt;/p></description></item><item><title>How Vitamin D fights Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy</title><link>/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy.html</link><pubDate>Sat, 22 Apr 2023 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#molecular-insights-into-the-pathogenic-impact-of-vitamin-d-deficiency-in-neurological-disorders">Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="molecular-insights-into-the-pathogenic-impact-of-vitamin-d-deficiency-in-neurological-disorders">Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders&lt;/h4>
&lt;p>Biomed Pharmacother. 2023 Apr 19;162:114718. &lt;a href="https://doi.org/10.1016/j.biopha.2023.114718">doi: 10.1016/j.biopha.2023.114718&lt;/a>&lt;/p>
&lt;p>Md Jamir Anwar 1, Sattam Khulaif Alenezi 2, Ahmad Hamad Alhowail 3&lt;/p>
&lt;h5 id="charts-of-impact-of-vitamin-d">Charts of impact of Vitamin D&lt;/h5>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/alz-and-d.jpg" alt="image" width="900">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pd-vit-d.jpg" alt="image" width="900">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ms-and-d.jpg" alt="image" width="900">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/epilepsy.jpg" alt="image" width="900">
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc-insights.jpg" alt="image" width="600">
&lt;p>Neurological disorders are the major cause of disability, leading to a decrease in quality of life by impairing cognitive, sensorimotor, and motor functioning. Several factors have been proposed in the pathogenesis of neurobehavioral changes, including nutritional, environmental, and genetic predisposition. Vitamin D (VD) is an environmental and nutritional factor that is widely distributed in the central nervous system&amp;rsquo;s subcortical grey matter, neurons of the substantia nigra, hippocampus, thalamus, and hypothalamus. It is implicated in the regulation of several brain functions by preserving neuronal structures. It is a hormone rather than a nutritional vitamin that exerts a regulatory role in the pathophysiology of several neurological disorders, including Alzheimer&amp;rsquo;s disease, Parkinson&amp;rsquo;s disease, epilepsy, and multiple sclerosis.&lt;/p></description></item><item><title>Parkinson's Disease 25 percent more likely if air pollution (likely lower Vitamin D)</title><link>/posts/parkinsons-disease-25-percent-more-likely-if-air-pollution-likely-lower-vitamin-d.html</link><pubDate>Tue, 11 Apr 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-25-percent-more-likely-if-air-pollution-likely-lower-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#mississippiohio-river-valley-linked-to-higher-risk-of-parkinsons-disease">Mississippi–Ohio River valley linked to higher risk of Parkinson’s disease&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="mississippiohio-river-valley-linked-to-higher-risk-of-parkinsons-disease">Mississippi–Ohio River valley linked to higher risk of Parkinson’s disease&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.mdedge.com/neurology/article/262306/parkinsons-disease/mississippi-ohio-river-valley-linked-higher-risk?ecd=WNL_EVE_230411_mdedge">MDEdge&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>&amp;ldquo;In total, researchers identified 83,674 Medicare beneficiaries with incident Parkinson’s disease, with &lt;strong>434&lt;/strong> new cases per 100,000 people in the highest exposure group, compared with &lt;strong>359&lt;/strong> new cases per 100,000 people in the lowest-exposure group. The relative risk for Parkinson’s disease increased in the highest quartile of PM2.5 by 25%, compared with the lowest quartile after adjusting for factors such as age, smoking status, and health care usage (95% confidence interval, 20%–29%).&amp;rdquo;&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>Comment by VitaminDWiki&lt;br>
Due to less getting outdoors due to air pollution and less vitamin D from the sun due to the pollution&lt;/strong>&lt;/p></description></item><item><title>Parkinson's Disease 5X more likely if Trichloroethylene (TCE, wonder about Vit D)</title><link>/posts/parkinsons-disease-5x-more-likely-if-trichloroethylene-tce-wonder-about-vit-d.html</link><pubDate>Fri, 24 Mar 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-5x-more-likely-if-trichloroethylene-tce-wonder-about-vit-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#trichloroethylene-an-invisible-cause-of-parkinsons-disease">Trichloroethylene: An Invisible Cause of Parkinson’s Disease?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review-of-study-includes-other-research-by-dr-dorsey-principal-author---march-2023">Review of study includes other research by Dr. Dorsey, principal author - March 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comments-on-this-study-and-how-to-avoid-tce----april-2023">Comments on this study and how to avoid TCE - April 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="trichloroethylene-an-invisible-cause-of-parkinsons-disease">Trichloroethylene: An Invisible Cause of Parkinson’s Disease?&lt;/h4>
&lt;p>Journal of Parkinson&amp;rsquo;s Disease, vol. 13, no. 2, pp. 203-218, 2023 DOI: 10.3233/JPD-225047&lt;/p>
&lt;p>&lt;strong>Dorsey&lt;/strong> , E. Raya; b; 1; * | Zafar, Maryama; 1 | Lettenberger, Samantha E.a | Pawlik, Meghan E.a | Kinel, Dana; b | Frissen, Myrthec | Schneider, Ruth B.a; b | Kieburtz, Karla; b | Tanner, Caroline M.d | De Miranda, Briana R.e | Goldman, Samuel M.f | Bloem, Bastiaan R.c&lt;/p></description></item><item><title>Parkinson’s Disease, low vitamin D and Vit. D genetics</title><link>/posts/parkinsons-disease-low-vitamin-d-and-vit-d-genetics.html</link><pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-low-vitamin-d-and-vit-d-genetics.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-genetic-polymorphisms-of-vitamin-d-associated-genes-in-parkinsons-disease">Vitamin D deficiency and genetic polymorphisms of Vitamin D-associated genes in Parkinson’s Disease&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-deficiency-and-genetic-polymorphisms-of-vitamin-d-associated-genes-in-parkinsons-disease">Vitamin D deficiency and genetic polymorphisms of Vitamin D-associated genes in Parkinson’s Disease&lt;/h4>
&lt;p>European Journal of Neuroscience preprint DOI: 10.22541/au.167407862.25881100/v1&lt;/p>
&lt;p>Barnali Ray Basu1, Randrita Pal1, Supriyo Choudhury2, Hrishikesh Kumar2, Sanjit Dey3, and Nilansu Das1&lt;/p>
&lt;p>1Surendranath College&lt;/p>
&lt;p>2Institute of Neurosciences Kolkata&lt;/p>
&lt;p>3University of Calcutta Faculty Council for Post-Graduate Studies in Science&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/d-and-pd.jpg" alt="image" width="800">
&lt;p>Parkinson’s Disease (PD) and vitamin D share a unique link as Vitamin D deficiency (VDD) prevails in PD. Thus, an in-depth understanding of Vitamin D biology in PD might be crucial for therapeutic strategies emphasizing Vitamin D. Specifically, explicating the effect of VDD and genetic polymorphisms of vitamin D-associated genes in PD, like&lt;/p></description></item><item><title>Parkinson's Disease and gut microbiome - several studies</title><link>/posts/parkinsons-disease-and-gut-microbiome-several-studies.html</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-gut-microbiome-several-studies.html</guid><description>&lt;p>&lt;strong>Strong association, unknown cause-affect direction&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Note: Vitamin D massively changes the composiition of gut bacteria&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-levels-change-gut-microbiota-25-study-review">Vitamin D levels change Gut Microbiota – 25 study review Sept 2021&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/gut-microbiome-massively-changed-by-weekly-vitamin-d">Gut microbiome massively changed by weekly vitamin D – July 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#those-with-pd-have-7x-higherlower-amounts-of-certain-gut-bacteria---nov-2022">Those with PD have 7X higher/lower amounts of certain gut bacteria - Nov 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#perspective-on-pathogenesis-and-treatment-butyrate-may-help---nov-2022">Perspective on pathogenesis and treatment (Butyrate may help) - Nov 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#new-insights-from-meta-analysis---jan-2022">New insights from meta-analysis - Jan 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a--cause--or-a-consequence---2020">A cause or a consequence? - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#exploring-human-genome-gut-microbiome-interaction-in-parkinsons-disease---aug-2021">Exploring human-genome gut-microbiome interaction in Parkinson’s disease - Aug 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="those-with-pd-have-7x-higherlower-amounts-of-certain-gut-bacteria---nov-2022">Those with PD have 7X higher/lower amounts of certain gut bacteria - Nov 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.trialsitenews.com/a/parkinsons-disease-may-start-in-the-gut-and-spread-to-the-brain-f3c8de42">Parkinson&amp;rsquo;s Disease May Start in the Gut and Spread to the Brain&lt;/a> Trial Site News&lt;/strong>&lt;/p></description></item><item><title>How Vitamin D fights neurodegeneration (Multiple Sclerosis, Alzheimer’s, Dementia, etc)</title><link>/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc.html</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-neurodegenerative-diseases">Vitamin D and neurodegenerative diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-neurodegenerative-diseases">Vitamin D and neurodegenerative diseases&lt;/h4>
&lt;p>Heliyon &lt;a href="https://doi.org/10.1016/j.heliyon.2023.e12877">https://doi.org/10.1016/j.heliyon.2023.e12877&lt;/a>&lt;/p>
&lt;p>Weixia Wang 1 YijinLi 1 Xianfang Meng 1&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/neurodegeneration.jpg" alt="image" width="700">
&lt;p>Neurodegenerative diseases, featured by progressive loss of structure or function of neurons, are considered incurable at present. Movement disorders like tremor and postural instability, cognitive or behavioral disorders such as memory impairment are the most common symptoms of them and the growing patient population of neurodegenerative diseases poses a serious threat to public health and a burden on economic development. Hence, it is vital to prevent the occurrence of the diseases and delay their progress. Vitamin D can be transformed into a hormone in vivo with both genomic and non-genomic actions, exerting diverse physiological effects.&lt;/p></description></item><item><title>Vitamin D Status and Parkinson’s Disease</title><link>/posts/vitamin-d-status-and-parkinsons-disease.html</link><pubDate>Sat, 24 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-status-and-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#brain-sci-2022-jun-126-790">Brain Sci. 2022 Jun; 12(6): 790.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="brain-sci-2022-jun-126-790">Brain Sci. 2022 Jun; 12(6): 790.&lt;/h4>
&lt;p>&lt;a href="https://doi.org/10.3390/brainsci12060790">doi: 10.3390/brainsci12060790&lt;/a>&lt;/p>
&lt;p>Michela Barichella,1,2,† Federica Garrì,2,*† Serena Caronni,2 Carlotta Bolliri,2 Luciano Zocchi,3 Maria Carmela Macchione,2 Valentina Ferri,2 Daniela Calandrella,2 and Gianni Pezzoli2&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc-pd.jpg" alt="image" width="600">
&lt;p>Parkinson’s disease (PD) is a complex and progressive neurodegenerative disease, characterized by resting tremor, rigidity, slowness of movement, and postural instability. Furthermore, PD is associated with a wide spectrum of non-motor symptoms that add to overall disability. In recent years, some investigations, from basic science to clinical applications, have focused on the role of vitamin D in PD, often with controversial findings. Vitamin D has widespread effects on several biological processes in the central nervous system, including neurotransmission in dopaminergic neural circuits. Various studies have recorded lower levels of vitamin D in PD patients than in healthy controls. Low vitamin D status has also been correlated with the risk for PD and motor severity, whereas less is known about the effects vitamin D has on cognitive function and other non-motor symptoms. This review aims to better characterize the correlation between vitamin D and PD, clarify the role of vitamin D in PD prevention and treatment, and discuss avenues for future research in this field.&lt;/p></description></item><item><title>Brain and Vitamin D - many studies</title><link>/posts/brain-and-vitamin-d-many-studies.html</link><pubDate>Tue, 18 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/brain-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#nervous-system-disorders-now-the-top-cause-of-illness---march-2024">Nervous system disorders now the top cause of illness - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#brain-problems-reduced-in-both-fetus-and-adult-by-vitamin-d--oct-2022">Brain problems reduced in both fetus and adult by Vitamin D – Oct 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#brain-and-vitamin-d-chart---2023">Brain and Vitamin D chart - 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#microglia-and-brain-disorders-the-role-of-vitamin-d-and-its-receptor---july-2023">Microglia and Brain Disorders: The Role of Vitamin D and Its Receptor - July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-a-fetus-with-adequate-vitamin-d-will-have-fewer-brain-problems">It appears that a fetus with adequate Vitamin D will have fewer brain problems&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-an-adult-with-adequate-vitamin-d-will-have-fewer-brain-problems">It appears that an adult with adequate Vitamin D will have fewer brain problems&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-fails-to-mention-that-vitamin-d-levels-in-cells-can-be-much-less-than-that-in-blood-gene-problems">Study fails to mention that Vitamin D levels in cells can be much less than that in blood (gene problems)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="nervous-system-disorders-now-the-top-cause-of-illness---march-2024">Nervous system disorders now the top cause of illness - March 2024&lt;/h4>
&lt;p>&lt;a href="https://www.yahoo.com/news/surging-nerve-system-disorders-now-000902683.html?utm_source=substack&amp;amp;utm_medium=email">Surging nervous system disorders now top cause of illness: study&lt;/a>&lt;/p></description></item><item><title>Neuro problems (AD, PD, MSA) associated with poor vitamin D genes (CYP27A1, CYP27B1)</title><link>/posts/neuro-problems-ad-pd-msa-associated-with-poor-vitamin-d-genes-cyp27a1-cyp27b1.html</link><pubDate>Thu, 08 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/neuro-problems-ad-pd-msa-associated-with-poor-vitamin-d-genes-cyp27a1-cyp27b1.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#role-of-cytochrome-p450-for-vitamin-d-metabolisms-in-patients-with-neurodegenerative-disorders">Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="role-of-cytochrome-p450-for-vitamin-d-metabolisms-in-patients-with-neurodegenerative-disorders">Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders&lt;/h4>
&lt;p>Clinical Parkinsonism &amp;amp; Related Disorders Volume 7, 2022, 100162 &lt;a href="https://doi.org/10.1016/j.prdoa.2022.100162">https://doi.org/10.1016/j.prdoa.2022.100162&lt;/a>&lt;/p>
&lt;p>AsakoKakimotoabHiromuOguraaMidoriSuenagacTakayasuMishimaaShinsukeFujiokaaShinjiOumaaYoichiMatsunagaa YoshioTsuboia&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cyp-neurodegen.jpg" alt="image" width="500">
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Low serum concentrations of CYP27A1 in AD, PD and MSA patients.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Low serum concentrations of CYP27B1 in MSA patients.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Serum P450 concentrations affect VD metabolites in neurodegenerative disorders.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>Introduction&lt;/p>
&lt;p>We previously reported lower serum 25-hydroxyvitamin D concentrations in patients with Alzheimer’s disease (AD), Parkinson’s disease (PD) and Multiple system atrophy (MSA) compared to healthy controls (HC), whereas 1,25-di-hydroxyvitamin D levels were solely lower in MSA patients. We investigate serum concentrations of P450 involved in Vitamin D(VD) hydroxylation to clarify the responsible hydroxylase for the low serum concentrations of VD metabolites.&lt;/p></description></item><item><title>Less Parkinson’s Disease if more vitamin D</title><link>/posts/less-parkinsons-disease-if-more-vitamin-d.html</link><pubDate>Fri, 17 Jun 2022 00:00:00 +0000</pubDate><guid>/posts/less-parkinsons-disease-if-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-status-and-parkinsons-disease">Vitamin D Status and Parkinson’s Disease&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-status-and-parkinsons-disease">Vitamin D Status and Parkinson’s Disease&lt;/h4>
&lt;p>Brain Sci. 2022, 12(6), 790; &lt;a href="https://doi.org/10.3390/brainsci12060790">https://doi.org/10.3390/brainsci12060790&lt;/a>&lt;/p>
&lt;p>by Michela Barichella 1,2,†,Federica Garrì 2,*,†,Serena Caronni 2,Carlotta Bolliri 2,Luciano Zocchi 3, Maria Carmela Macchione 2,Valentina Ferri 2,Daniela Calandrella 2 and Gianni Pezzoli 2&lt;/p>
&lt;p>1 Parkinson Institute, ASST Gaetano Pini-CTO, 20126 Milan, Italy&lt;/p>
&lt;p>2 Fondazione Grigioni per il Morbo di Parkinson, 20126 Milan, Italy&lt;/p>
&lt;p>3 Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Sezione di Fisiologia, 20133 Milan, Italy&lt;/p></description></item><item><title>Parkinson’s Disease 3 X more likely if a poor Vitamin D Receptor – May – 2022</title><link>/posts/parkinsons-disease-3-x-more-likely-if-a-poor-vitamin-d-receptor-may-2022.html</link><pubDate>Fri, 06 May 2022 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-3-x-more-likely-if-a-poor-vitamin-d-receptor-may-2022.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#genetic-variability-of-the-vitamin-d-receptor-affects-susceptibility-to-parkinsons-disease-and-dopaminergic-treatment-adverse-events">Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson&amp;rsquo;s Disease and Dopaminergic Treatment Adverse Events&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="genetic-variability-of-the-vitamin-d-receptor-affects-susceptibility-to-parkinsons-disease-and-dopaminergic-treatment-adverse-events">Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson&amp;rsquo;s Disease and Dopaminergic Treatment Adverse Events&lt;/h4>
&lt;p>Front Aging Neurosci. 2022 Apr 19;14:853277. &lt;a href="https://doi.org/10.3389/fnagi.2022.853277">doi: 10.3389/fnagi.2022.853277&lt;/a>&lt;/p>
&lt;p>Sara Redenšek 1, Tilen Kristanc 1, Tanja Blagus 1, Maja Trošt 2, Vita Dolžan 1&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pd-vdr.jpg" alt="image" width="500">
&lt;p>Vitamin D is a lipid-soluble molecule and an important transcriptional regulator in many tissues and organs, including the brain. Its role has been demonstrated also in Parkinson&amp;rsquo;s disease (PD) pathogenesis. Vitamin D receptor (VDR) is responsible for the initiation of vitamin D signaling cascade. The aim of this study was to assess the associations of VDR genetic variability with PD risk and different PD-related phenotypes. We genotyped 231 well characterized PD patients and 161 healthy blood donors for six VDR single nucleotide polymorphisms, namely rs739837, rs4516035, rs11568820, rs731236, rs2228570, and rs1544410. We observed that VDR rs2228570 is associated with PD risk (p &amp;lt; 0.001). Additionally, we observed associations of specific VDR genotypes with adverse events of dopaminergic treatment. VDR rs1544410 (GG vs. GA + AA: p = 0.005; GG vs. GA: p = 0.009) was associated with the occurrence of visual hallucinations and VDR rs739837 (TT vs. GG: p = 0.036), rs731236 (TT vs. TC + CC: p = 0.011; TT vs. TC: p = 0.028; TT vs. CC: p = 0.035), and rs1544410 (GG vs. GA: p = 0.014) with the occurrence of orthostatic hypotension. We believe that the reported study may support personalized approach to PD treatment, especially in terms of monitoring vitamin D level and vitamin D supplementation in patients with high risk VDR genotypes.&lt;/p></description></item><item><title>Cognitive impairment 5 percent less likely for each ng more of Vitamin D (Parkinson’s)</title><link>/posts/cognitive-impairment-5-percent-less-likely-for-each-ng-more-of-vitamin-d-parkinsons.html</link><pubDate>Sun, 01 May 2022 00:00:00 +0000</pubDate><guid>/posts/cognitive-impairment-5-percent-less-likely-for-each-ng-more-of-vitamin-d-parkinsons.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#correlation-between-serum-25ohd-and-cognitive-impairment-in-parkinsons-disease">Correlation between serum 25(OH)D and cognitive impairment in Parkinson&amp;rsquo;s disease&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="correlation-between-serum-25ohd-and-cognitive-impairment-in-parkinsons-disease">Correlation between serum 25(OH)D and cognitive impairment in Parkinson&amp;rsquo;s disease&lt;/h4>
&lt;p>J Clin Neurosci . 2022 Apr 27;100:192-195. &lt;a href="https://doi.org/10.1016/j.jocn.2022.04.015">doi: 10.1016/j.jocn.2022.04.015&lt;/a> PDF behind paywall&lt;/p>
&lt;p>Han Wu 1, Hafiz Khuram Raza 1, Zhen Li 1, Zeheng Li 1, Jie Zu 1, Chuanying Xu 1, Di Yang 1, Guiyun Cui 2&lt;/p>
&lt;p>This study aimed to investigate the relationship between serum 25(OH)D and cognitive impairment in patients with Parkinson&amp;rsquo;s disease (PD), hoping to provide possible ideas for the diagnosis and prevention of PD with cognitive impairment. Vitamin D is a neurosteroid with neurotrophic and neuroprotective functions, playing an important role in PD and its progression. In the present study, serum 25(OH)D levels were significantly decreased in PD patients (45.86 ± 14.81 nmol/L) compared to healthy controls(56.54 ± 14.00 nmol/L) (P &amp;lt; 0.001), and significant differences were also observed in PD patients with normal cognition (PD-NC), PD patients with mild cognitive impairment (PD-MCI) and PD patients with dementia (PDD)(P &amp;lt; 0.05). Moreover, there was a positive correlation between serum 25(OH)D levels and Montreal cognitive assessment(MoCA) scores (r = 0.489,P &amp;lt; 0.001).&lt;/p></description></item><item><title>Vitamin D associated with Parkinson’s Disease in 55 studies, more studies needed</title><link>/posts/vitamin-d-associated-with-parkinsons-disease-in-55-studies-more-studies-needed.html</link><pubDate>Sat, 26 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-associated-with-parkinsons-disease-in-55-studies-more-studies-needed.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-parkinsons-disease---march-2022">Vitamin D and Parkinson&amp;rsquo;s Disease - March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#still-unsure--about-vitamin-d-dose-and-vdr-to-fight-parkinsons-disease---june-2022">Still unsure about vitamin D dose and VDR to fight Parkinson&amp;rsquo;s Disease - June 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dr-coimbra-treating-autoimmune-diseases-with-high-dose-vitamin-d">Dr. Coimbra treating autoimmune diseases with high-dose vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#testimonials-of-parkinsons-disease-treated-by-coimbra-protocol---2018">Testimonials of Parkinson&amp;rsquo;s Disease treated by Coimbra Protocol - 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#as-with-many-other-health-problems-more-than-vitamin-d-will-likely-be-needed">As with many other health problems, more than Vitamin D will likely be needed&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-parkinsons-disease---march-2022">Vitamin D and Parkinson&amp;rsquo;s Disease - March 2022&lt;/h4>
&lt;p>Nutrients. 2022 Mar 14;14(6):1220. &lt;a href="https://doi.org/10.3390/nu14061220.">doi: 10.3390/nu14061220.&lt;/a>&lt;/p>
&lt;p>Antonia Pignolo 1, Sergio Mastrilli 1, Chiara Davì 1, Valentina Arnao 2, Paolo Aridon 1, Felipe Augusto Dos Santos Mendes 3, Cesare Gagliardo 1, Marco D&amp;rsquo;Amelio 1&lt;/p></description></item><item><title>Parkinson’s Disease might be fought by Vitamin D and the activation of the Vitamin D Receptor</title><link>/posts/parkinsons-disease-might-be-fought-by-vitamin-d-and-the-activation-of-the-vitamin-d-receptor.html</link><pubDate>Mon, 14 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-might-be-fought-by-vitamin-d-and-the-activation-of-the-vitamin-d-receptor.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-parkinsons-disease---march-2022">Vitamin D and Parkinson’s Disease - March 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-parkinsons-disease---march-2022">Vitamin D and Parkinson’s Disease - March 2022&lt;/h4>
&lt;p>Nutrients 2022, 14(6), 1220; &lt;a href="https://doi.org/10.3390/nu14061220">https://doi.org/10.3390/nu14061220&lt;/a>&lt;/p>
&lt;p>by Antonia Pignolo 1ORCID,Sergio Mastrilli 1,Chiara Davì 1ORCID,Valentina Arnao 2,Paolo Aridon 1,Felipe Augusto dos Santos Mendes 3ORCID,Cesare Gagliardo 1ORCID andMarco D’Amelio 1,*&lt;/p>
&lt;p>1 Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy&lt;/p>
&lt;p>2 UO Neurologia e Stroke Unit, Azienda di Rilievo Nazionale ad Alta Specializzazione, Ospedali Civico Di Cristina Benfratelli, 90134 Palermo, Italy&lt;/p></description></item><item><title>White Matter Hyperintensities (brain) 1.8X more likely if 10 ng less vitamin D - meta-analysis</title><link>/posts/white-matter-hyperintensities-brain-18x-more-likely-if-10-ng-less-vitamin-d-meta-analysis.html</link><pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/white-matter-hyperintensities-brain-18x-more-likely-if-10-ng-less-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="impact-of-25-hydroxy-vitamin-d-on-white-matter-hyperintensity-in-elderly-patients-a-systematic-review-and-meta-analysis">Impact of 25-Hydroxy Vitamin D on White Matter Hyperintensity in Elderly Patients: A Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Front Neurol. 2022 Jan 14;12:721427. &lt;a href="https://doi.org/10.3389/fneur.2021.721427.">doi: 10.3389/fneur.2021.721427.&lt;/a>&lt;/p>
&lt;p>Yilei Zhao 1, Jingfeng Xu 1, Zhan Feng 1, Jincheng Wang 1&lt;/p>
&lt;p>Some studies show that low serum vitamin D levels are associated with white matter hyperintensity (WMH), while other studies report no association. This meta-analysis aimed to investigate the presence of an association between serum 25-hydroxy vitamin D &lt;span>[25(OH)D]&lt;/span> levels and WMH. PubMed, Embase, the Cochrane Library, CNKI, WANFANG, and VIP were searched for available papers published up to December 2020. The outcomes were the odds ratios (ORs) with 95% confidence intervals (CIs) for the association between different vitamin D statuses and WMH. All meta-analyses were performed using a random-effects model. Five studies (4393 patients) were included. Compared with sufficient 25(OH)D levels, 25(OH)D deficiency was not associated with WMH (OR = 1.67, 95%CI: 0.92-3.04; I2 = 70.2%, P heterogeneity = 0.009), nor was 25(OH)D insufficiency (OR = 1.21, 95%CI: 0.89-1.65; I2 = 48.1%, P heterogeneity = 0.103).&lt;/p></description></item><item><title>Vitamin D and its’ role in Parkinson’s disease patients with COVID</title><link>/posts/vitamin-d-and-its-role-in-parkinsons-disease-patients-with-covid.html</link><pubDate>Wed, 12 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-its-role-in-parkinsons-disease-patients-with-covid.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-its-role-in-parkinsons-disease-patients-with-sars-cov-2-infection-a-review-article---jan-2022">Vitamin D and its’ role in Parkinson’s disease patients with SARS-CoV-2 infection. A review article - Jan 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-its-role-in-parkinsons-disease-patients-with-sars-cov-2-infection-a-review-article---jan-2022">Vitamin D and its’ role in Parkinson’s disease patients with SARS-CoV-2 infection. A review article - Jan 2022&lt;/h4>
&lt;p>Interdisciplinary Neurosurgery: Advanced Techniques and Case Management 27 (2022) 101441&lt;/p>
&lt;p>Ahmed Y Azzama’*, Sherief Ghozyb, Mohammed A Azabc&lt;/p>
&lt;p>a October 6 University Faculty of Medicine, Giza, Egypt&lt;/p>
&lt;p>b Department of Radiology, Mayo Clinic, Rochester, MN, USA&lt;/p></description></item><item><title>SARS-CoV-2 may increase the risk of Parkinson's Disease</title><link>/posts/sars-cov-2-may-increase-the-risk-of-parkinsons-disease.html</link><pubDate>Fri, 17 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/sars-cov-2-may-increase-the-risk-of-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#sars-cov-2-protein-may-drive-parkinsons-diseasehttpsrsibfoundmyfitnesscommkclfz9opcfd6_vns-1bvbsrge9edspzwduv3rmhebeu_akbotqhou96leuz-oqgyjdjoo6g8l2fhkdcvp3ghhmgtglqqww1b7eizef6e8pk61hwrbbkntmdoeabssbdkp_nfn4rtlvjup_hnbe1zqyi1x4zab8rmlgrycuvpvu1vncvcmy2dvuato5lkigwqg_c87aqp8zyu8c8unoubqmikhjewolq3xv_ockfohhbgcbwy07cy-xdvngg6-fk-dw5n4agmigto1mic6a2538fjr4lmipg_yq-dr-rhonda-patrick---dec-17--2021">&lt;a href="https://r.sib.foundmyfitness.com/mk/cl/f/z9opcFd6_VNS-1BvBSrGe9edsPZwDuV3RMhebeu_AKBoTQHOu96LeUZ-oqGyJDjOo6G8l2fhKdCvP3gHhMgtGlQqWW1b7eIzEf6E8pk61HWrbBKNTMdOEaBSSBdKp_nFN4RTlvJUP_Hnbe1zqYi1X4ZaB8RMlgRYCuvPvU1vncVcmY2Dvuato5lkiGWqG_C87AQp8ZYu8C8uNOUbqMIKhjeWolQ3xV_oCkfoHhBgCBwY07Cy-XdVNGg6-fk-dw5n4aGMIGTo1MIC6a2538fjR4LmIPg_yQ">SARS-CoV-2 protein may drive Parkinson&amp;rsquo;s disease.&lt;/a> Dr. Rhonda Patrick - Dec 17 , 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="sars-cov-2-protein-may-drive-parkinsons-diseasehttpsrsibfoundmyfitnesscommkclfz9opcfd6_vns-1bvbsrge9edspzwduv3rmhebeu_akbotqhou96leuz-oqgyjdjoo6g8l2fhkdcvp3ghhmgtglqqww1b7eizef6e8pk61hwrbbkntmdoeabssbdkp_nfn4rtlvjup_hnbe1zqyi1x4zab8rmlgrycuvpvu1vncvcmy2dvuato5lkigwqg_c87aqp8zyu8c8unoubqmikhjewolq3xv_ockfohhbgcbwy07cy-xdvngg6-fk-dw5n4agmigto1mic6a2538fjr4lmipg_yq-dr-rhonda-patrick---dec-17--2021">&lt;a href="https://r.sib.foundmyfitness.com/mk/cl/f/z9opcFd6_VNS-1BvBSrGe9edsPZwDuV3RMhebeu_AKBoTQHOu96LeUZ-oqGyJDjOo6G8l2fhKdCvP3gHhMgtGlQqWW1b7eIzEf6E8pk61HWrbBKNTMdOEaBSSBdKp_nFN4RTlvJUP_Hnbe1zqYi1X4ZaB8RMlgRYCuvPvU1vncVcmY2Dvuato5lkiGWqG_C87AQp8ZYu8C8uNOUbqMIKhjeWolQ3xV_oCkfoHhBgCBwY07Cy-XdVNGg6-fk-dw5n4aGMIGTo1MIC6a2538fjR4LmIPg_yQ">SARS-CoV-2 protein may drive Parkinson&amp;rsquo;s disease.&lt;/a> Dr. Rhonda Patrick - Dec 17 , 2021&lt;/h4>
&lt;p>Scientists have identified an emerging pattern of associations between SARS-CoV-2 (the virus that causes COVID-19) and Parkinson’s disease. For example, the loss of smell is one of the most common symptoms reported in SARS-CoV-2 infection, but it is also an early symptom of Parkinson’s disease, often &lt;a href="https://r.sib.foundmyfitness.com/mk/cl/f/LtpYe4mV1_oH10TMOhqW6ZIqp2TKTEYpSQbjBhtvzBQqf08RtaNSQUAE1LGGIK2z7ZgDhP18yoQdkEFqLlB9Pws1bpxXA-Vcka1axynY4XUgHwCCisvX_owQZ8fGT5Rquxqsu6dhtRCRV10JKlnik1faVCqYYhImYtu%3Cstrike%3EwBtJUmfSflrshddX2Q2KmIPst54VG0WJYCi4qgMhrw9_ftNPWhS_giQUEuPuZUSNU1eghPrNGlpRJIl0uOG4dAe2kZJ_4KcwQ">preceding diagnosis by many years&lt;/a>. In addition, some recent case reports describe patients who &lt;a href="https://r.sib.foundmyfitness.com/mk/cl/f/WtXf07VNxb2TxLANzzVTq78VjGILedQSYg-I0rRJbY7MJOvxheZYIV9caxMJUPD85T5QxuhprKmYCBYnt2p-75pM6_bkgG38U7spaVfGziW_QHaRBWO1KCszgf0fk2EXnbmBkHmqbgzwT19LWh4oYEwGaotBrksu8kxLhglSzpbb3M0qOa0g7di9AVPUMdb4DY1gaEKr7W-URS84I4QAtFV5S-l4jN-sEMTgwO_NNu9DaNZ8_JSozJ9By0XWJXAZH4oxgCvEGe0z-w03wanx7BB8Hxg-0Asblwvb">presented with probable Parkinson’s disease after recovering from severe SARS-CoV-2 infection&lt;/a>. Now, evidence from a recent study suggests that the SARS-CoV-2 nucleocapsid protein drives aggregation of alpha synuclein, a hallmark of Parkinson’s disease. &lt;/p></description></item><item><title>Those with Parkinson's disease should take vitamin D to reduce COVID-19 risk</title><link>/posts/those-with-parkinsons-disease-should-take-vitamin-d-to-reduce-covid-19-risk.html</link><pubDate>Fri, 11 Jun 2021 00:00:00 +0000</pubDate><guid>/posts/those-with-parkinsons-disease-should-take-vitamin-d-to-reduce-covid-19-risk.html</guid><description>&lt;h4 id="potential-role-of-vitamin-d-in-the-elderly-to-resist-covid-19-and-to-slow-progression-of-parkinsons-disease">Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson&amp;rsquo;s Disease&lt;/h4>
&lt;p>Brain Sci. 2020, 10, 284; doi:10.3390/brainsci10050284&lt;/p>
&lt;p>Casey A. Hribar1, Peter H. Cobbold 2 and Frank C. Church&lt;/p>
&lt;p>Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27759, USA; &lt;a href="mailto:casey_hribar@med.unc.edu">casey_hribar@med.unc.edu&lt;/a>&lt;/p>
&lt;p>Department of Human Anatomy and Cell Biology, University of Liverpool, Liverpool L69 3EG, UK; &lt;a href="mailto:pcobbold@fireflyuk.net">pcobbold@fireflyuk.net&lt;/a>&lt;/p></description></item><item><title>COVID-19 mortality for Parkinson’s is 1 in 5, speculates that vitamin D could help</title><link>/posts/covid-19-mortality-for-parkinsons-is-1-in-5-speculates-that-vitamin-d-could-help.html</link><pubDate>Mon, 22 Mar 2021 00:00:00 +0000</pubDate><guid>/posts/covid-19-mortality-for-parkinsons-is-1-in-5-speculates-that-vitamin-d-could-help.html</guid><description/></item><item><title>Resveratrol fights Parkinson, Alzheimers, Diabetes, Cardiovascular, ALS, Stroke, etc.</title><link>/posts/resveratrol-fights-parkinson-alzheimers-diabetes-cardiovascular-als-stroke-etc.html</link><pubDate>Sun, 22 Mar 2020 00:00:00 +0000</pubDate><guid>/posts/resveratrol-fights-parkinson-alzheimers-diabetes-cardiovascular-als-stroke-etc.html</guid><description/></item><item><title>Parkinson’s disease 1.6X more likely if a poor Vitamin D Receptor – meta-analysis</title><link>/posts/parkinsons-disease-16x-more-likely-if-a-poor-vitamin-d-receptor-meta-analysis.html</link><pubDate>Tue, 28 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-16x-more-likely-if-a-poor-vitamin-d-receptor-meta-analysis.html</guid><description>&lt;h4 id="association-between-vitamin-d-receptor-polymorphisms-and-susceptibility-to-parkinsons-disease-an-updated-meta-analysis">Association Between Vitamin D Receptor Polymorphisms and Susceptibility to Parkinson&amp;rsquo;s Disease: An Updated Meta-Analysis&lt;/h4>
&lt;p>Neurosci Letters, 720, 134778 2020 Jan 21, DOI: 10.1016/j.neulet.2020.134778&lt;/p>
&lt;p>Jinzhao Gao 1, Jijun Teng 1, Zongchao Liu 1, Min Cai 1, Anmu Xie 2&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>The risk of &lt;span style="color:#F00;">44 &lt;/span> diseases at least double with poor &lt;a href="/posts/vitamin-d-receptor">Vitamin D Receptor&lt;/a> as of Oct 2019&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/tags/omega-3.html">Omega-3&lt;/a>,  &lt;a href="/posts/magnesium-and-vitamin-d">Magnesium&lt;/a>,  &lt;a href="/posts/zinc-and-vitamin-d">Zinc&lt;/a>,   &lt;a href="/tags/quercetin.html">Quercetin&lt;/a>,   &lt;a href="/posts/better-than-daily">non-daily Vit D&lt;/a>,  &lt;a href="/posts/curcumin-may-increase-vitamin-d-in-tissues-activates-vitamin-d-receptor">Curcumin&lt;/a>, intense exercise,   Ginger,   Essential oils, etc&lt;/strong>   &lt;strong>Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators&lt;/strong>&lt;/p></description></item><item><title>Parkinson patients: 60 % taking Vitamin D</title><link>/posts/parkinson-patients-60-percent-taking-vitamin-d.html</link><pubDate>Thu, 05 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/parkinson-patients-60-percent-taking-vitamin-d.html</guid><description>&lt;p>&lt;strong>Note by the founder of VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>A friend of mine got Parkinson&amp;rsquo;s Disease&lt;/p>
&lt;p>He started taking my recommendation of 4,000 IU of vitamin D daily&lt;/p>
&lt;p>    4,000 IU seemed like a big dose back in 2012&lt;/p>
&lt;p>    His symptoms almost went away&lt;/p>
&lt;p>    He got back to working in his machine shop. playing his guitar, and singing&lt;/p>
&lt;p>Unfortunately, his doctor thought it was too much&lt;/p>
&lt;p>My friend reduced his dose to 2,000 IU daily - Dr. orders&lt;/p></description></item><item><title>Parkinson’s Disease Summer School – therapies included 60-80 ng of Vitamin D</title><link>/posts/parkinsons-disease-summer-school-therapies-included-60-80-ng-of-vitamin-d.html</link><pubDate>Thu, 05 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-summer-school-therapies-included-60-80-ng-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-top-things-i-learned-in-parkinsons-summer-schoolhttpsparkinsonsnewstodaycom20190903top-six-parkinsons-summer-school">&lt;a href="https://parkinsonsnewstoday.com/2019/09/03/top-six-parkinsons-summer-school/">The Top Things I Learned in Parkinson’s Summer School&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-top-things-i-learned-in-parkinsons-summer-schoolhttpsparkinsonsnewstodaycom20190903top-six-parkinsons-summer-school">&lt;a href="https://parkinsonsnewstoday.com/2019/09/03/top-six-parkinsons-summer-school/">The Top Things I Learned in Parkinson’s Summer School&lt;/a>&lt;/h4>
&lt;p>$5,000 for 1 week conference/summer school&lt;/p>
&lt;p>Laurie K. Mischley, a naturopathic doctor, assembled approximately 60 people with Parkinson’s for a conference at Bastyr University’s Seattle campus in August. The six-day “summer school” included lectures, exercise classes, and nutrition advice designed to improve each patient’s experience with Parkinson’s and possibly slow progression&lt;/p>
&lt;p>Part of a project &lt;strong>&lt;a href="https://bastyr.edu/research/studies/complementary-alternative-medicine-care-parkinsons-disease-cam-care-pd">“Complementary &amp;amp; Alternative Medicine Care in Parkinson&amp;rsquo;s Disease (CAM Care in PD)&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Elderly with low vitamin D fall more often (Parkinson’s in this case)</title><link>/posts/elderly-with-low-vitamin-d-fall-more-often-parkinsons-in-this-case.html</link><pubDate>Thu, 29 Aug 2019 00:00:00 +0000</pubDate><guid>/posts/elderly-with-low-vitamin-d-fall-more-often-parkinsons-in-this-case.html</guid><description>&lt;h4 id="parkinsons-patients-with-low-vitamin-d-more-likely-to-fallhttpsarticlesmercolacomsitesarticlesarchive20190829vitamin-d-deficiency-parkinsons-diseaseaspxutm_sourcednlutm_mediumemailutm_contentart2utm_campaign20190829z1et_ciddm328843et_rid696535719-mercola">&lt;a href="https://articles.mercola.com/sites/articles/archive/2019/08/29/vitamin-d-deficiency-parkinsons-disease.aspx?utm_source=dnl&amp;amp;utm_medium=email&amp;amp;utm_content=art2&amp;amp;utm_campaign=20190829Z1&amp;amp;et_cid=DM328843&amp;amp;et_rid=696535719">Parkinson&amp;rsquo;s patients with low vitamin D more likely to fall&lt;/a> Mercola&lt;/h4>
&lt;p>&lt;strong>The study refered to found that falls in PD patients were associated with low vitamin D.&lt;br>
That study does not appear to compare falling rate to those with low vitamin D levels without PD.&lt;/strong>&lt;/p></description></item><item><title>Omega-3 prevents Parkinson’s Disease – Review of RCT</title><link>/posts/omega-3-prevents-parkinsons-disease-review-of-rct.html</link><pubDate>Thu, 01 Aug 2019 00:00:00 +0000</pubDate><guid>/posts/omega-3-prevents-parkinsons-disease-review-of-rct.html</guid><description/></item><item><title>Younger Parkinson’s patients had better balance after 10,000 IU of vitamin D for 16 weeks – RCT</title><link>/posts/younger-parkinsons-patients-had-better-balance-after-10000-iu-of-vitamin-d-for-16-weeks-rct.html</link><pubDate>Tue, 26 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/younger-parkinsons-patients-had-better-balance-after-10000-iu-of-vitamin-d-for-16-weeks-rct.html</guid><description/></item><item><title>Parkinson’s disease 20 percent more likely in Asians if poor Vitamin D Receptor – meta-analysis</title><link>/posts/parkinsons-disease-20-percent-more-likely-in-asians-if-poor-vitamin-d-receptor-meta-analysis.html</link><pubDate>Sun, 17 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-20-percent-more-likely-in-asians-if-poor-vitamin-d-receptor-meta-analysis.html</guid><description/></item><item><title>Parkinson’s patients 50X less likely to get even a little sun– meta-analysis</title><link>/posts/parkinsons-patients-50x-less-likely-to-get-even-a-little-sun-meta-analysis.html</link><pubDate>Wed, 23 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/parkinsons-patients-50x-less-likely-to-get-even-a-little-sun-meta-analysis.html</guid><description>&lt;h4 id="the-association-between-vitamin-d-status-vitamin-d-supplementation-sunlight-exposure-and-parkinsons-disease-a-systematic-review-and-meta-analysis">The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson’s Disease: A Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Med Sci Monit 2019; 25:666-674, DOI: 10.12659/MSM.912840&lt;/p>
&lt;p>Zonglei Zhou, Ruzhen Zhou, Zengqiao Zhang, Kunpeng Li&lt;/p>
&lt;p>Department of Epidemiology and Biostatistics, Sichuan University West China School of Public Health, Chengdu, Sichuan, China (mainland)&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>Also, this study found that Parkinson’s 2.6X more likely if &amp;lt; 20 ng/mL&lt;/p>
&lt;p>Note: Multiple Sclerosis is another disease for which UV appears to be better than Vitamin D&lt;/p></description></item><item><title>Vitamin D and neurological diseases such as stroke, Vascular Dementia, PD, MS</title><link>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</link><pubDate>Thu, 06 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</guid><description>&lt;p>&lt;strong>Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact&lt;/strong>&lt;/p>
&lt;p>International Journal of Molecular Sciences, 2018, 19, 2245; doi:10.3390/ijms19082245&lt;/p>
&lt;p>Rita Moretti &lt;a href="mailto:moretti@units.it">moretti@units.it&lt;/a>, Maria Elisa Morelli © and Paola Caruso&lt;/p>
&lt;p>Neurology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy; &lt;a href="mailto:mariaelisa.morelli@gmail.com">mariaelisa.morelli@gmail.com&lt;/a> (M.E.M.); &lt;a href="mailto:caruso.paola1983@libero.it">caruso.paola1983@libero.it&lt;/a> (P.C.)&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vdr-neurological-diseases.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-multiple-sclerosis-role-in-the-susceptibility-activity-and-treatment-of-the-disease">Vitamin D Deficiency and Multiple Sclerosis: Role in the Susceptibility, Activity, and Treatment of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiencies-and-ischemic-stroke">Vitamin D Deficiencies and Ischemic Stroke&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-neurodegenerative-diseases">Vitamin D Deficiency and Neurodegenerative Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>It is widely known that vitamin D receptors have been found in neurons and glial cells, and their highest expression is in the hippocampus, hypothalamus, thalamus and subcortical grey nuclei, and substantia nigra. Vitamin D helps the regulation of neurotrophin, neural differentiation, and maturation, through the control operation of growing factors synthesis (i.e., neural growth factor &lt;span>[NGF]&lt;/span> and glial cell line-derived growth factor (GDNF), the trafficking of the septohippocampal pathway, and the control of the synthesis process of different neuromodulators (such as acetylcholine &lt;span>[Ach]&lt;/span>, dopamine &lt;span>[DA]&lt;/span>, and gamma-aminobutyric &lt;span>[GABA]&lt;/span>). Based on these assumptions, we have written this review to summarize the potential role of vitamin D in neurological pathologies. This work could be titanic and the results might have been very fuzzy and even incoherent had we not conjectured to taper our first intentions and devoted our interests towards three mainstreams, demyelinating pathologies, vascular syndromes, and neurodegeneration. As a result of the lack of useful therapeutic options, apart from the disease-modifying strategies, the role of different risk factors should be investigated in neurology, as their correction may lead to the improvement of the cerebral conditions. We have explored the relationships between the gene-environmental influence and long-term vitamin D deficiency, as a risk factor for the development of different types of neurological disorders, along with the role and the rationale of therapeutic trials with vitamin D implementation.&lt;/p></description></item><item><title>Parkinson's Disease 2.1 X more likely if low Vitamin D – Meta-analysis</title><link>/posts/parkinsons-disease-21-x-more-likely-if-low-vitamin-d-meta-analysis.html</link><pubDate>Tue, 04 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-21-x-more-likely-if-low-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Young Diabetics had 3.8 X higher risk of Parkinson’s (perhaps low Mg or low Vitamin D)</title><link>/posts/young-diabetics-had-38-x-higher-risk-of-parkinsons-perhaps-low-mg-or-low-vitamin-d.html</link><pubDate>Thu, 21 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/young-diabetics-had-38-x-higher-risk-of-parkinsons-perhaps-low-mg-or-low-vitamin-d.html</guid><description>&lt;h4 id="association-between-diabetes-and-subsequent-parkinson-disease-a-record-linkage-cohort-studyhttpnneurologyorgcontentearly20180613wnl0000000000005771">&lt;a href="http://n.neurology.org/content/early/2018/06/13/WNL.0000000000005771">Association between diabetes and subsequent Parkinson disease A record-linkage cohort study&lt;/a>&lt;/h4>
&lt;p>Neurology DOI: &lt;a href="https://doi.org/10.1212/WNL.0000000000005771">https://doi.org/10.1212/WNL.0000000000005771&lt;/a>&lt;/p>
&lt;p>Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J. Noyce, Thomas T. Warner&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>Looked at hospital admission records for 8 million people over a 12 year time period&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Those admitted to hospital for diabetes aged 25-44 were 3.8 X more likely to later be admitted to hospital for Parkinson’s disease&lt;/p>
&lt;/li>
&lt;li>
&lt;p>VitaminDWiki suspects a much higher rate would have been found if had waited for the young adults to get into the senior age range typical for Parkinson’s disease (25 years instead of 12)&lt;/p></description></item><item><title>Concussion which caused unconsciousness increased risk of Parkinson's by 50 percent (300,000 military)</title><link>/posts/concussion-which-caused-unconsciousness-increased-risk-of-parkinsons-by-50-percent-300000-military.html</link><pubDate>Mon, 07 May 2018 00:00:00 +0000</pubDate><guid>/posts/concussion-which-caused-unconsciousness-increased-risk-of-parkinsons-by-50-percent-300000-military.html</guid><description>&lt;h4 id="even-a-mild-head-injury-increases-your-risk-for-parkinsons-diseasehttpsarticlesmercolacomsitesarticlesarchive20180503traumatic-brain-injury-linked-to-parkinsons-diseaseaspxutm_sourcednlutm_mediumemailutm_contentart1utm_campaign20180503z1et_ciddm204045et_rid294384812-mercola">&lt;a href="https://articles.mercola.com/sites/articles/archive/2018/05/03/traumatic-brain-injury-linked-to-parkinsons-disease.aspx?utm_source=dnl&amp;amp;utm_medium=email&amp;amp;utm_content=art1&amp;amp;utm_campaign=20180503Z1&amp;amp;et_cid=DM204045&amp;amp;et_rid=294384812">Even a Mild Head Injury Increases Your Risk for Parkinson&amp;rsquo;s Disease&lt;/a> Mercola&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&amp;quot; Here, “concussion” was defined as loss of consciousness for up to 30 minutes or alteration of consciousness and/or amnesia for up to 24 hours&amp;quot;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;Medical records of nearly 326,000 U.S. military veterans ranging in age from 31 to 65 were evaluated in this retrospective cohort study, showing that a TBI resulting in loss of consciousness raised the risk of Parkinson’s by 56 percent.&amp;rdquo;&lt;/p></description></item><item><title>Vitamin B12 and Parkinson’s Disease</title><link>/posts/vitamin-b12-and-parkinsons-disease.html</link><pubDate>Mon, 19 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-b12-and-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#low-vitamin-b12-and-parkinson-disease--may-2019">Low Vitamin B12 and Parkinson Disease – May 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#google-scholar-b12-parkinsons---18000-items-march-2022">Google Scholar: B12 parkinson&amp;rsquo;s - 18,000 items March 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="low-vitamin-b12-and-parkinson-disease--may-2019">Low Vitamin B12 and Parkinson Disease – May 2019&lt;/h4>
&lt;p>&lt;strong>Potential Link to Reduced Cholinergic Transmission and Severity of Disease&lt;/strong>&lt;/p>
&lt;p>Mayo Clinic COMMENTARY, ISSUE 5, P757-762, MAY 01, 2019 DOI:https://doi.org/10.1016/j.mayocp.2019.01.039&lt;/p>
&lt;p>Parkinson&amp;rsquo;s disease (PD) is a progressive neurodegenerative disease characterized by prominent motor dysfunction including rest tremor, bradykinesia, and rigidity responsive to levodopa. However, postural instability, freezing of gait, and cognitive impairment are important non–levodopa-responsive symptoms of PD and are significant risk factors for falls, leading to hospitalization, disability, and death.1 Treatments for key nonmotor symptoms of PD that might improve cognitive decline and postural instability are currently a major gap in PD therapeutics.&lt;/p></description></item><item><title>Hypothesis - Dysfunction of Autonomic Nervous System is associated with low vitamin D</title><link>/posts/hypothesis-dysfunction-of-autonomic-nervous-system-is-associated-with-low-vitamin-d.html</link><pubDate>Fri, 16 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/hypothesis-dysfunction-of-autonomic-nervous-system-is-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="is-vitamin-d-deficiency-implicated-in-autonomic-dysfunction">Is Vitamin D Deficiency Implicated in Autonomic Dysfunction?&lt;/h4>
&lt;p>J Pediatr Neurosci. 2017 Apr-Jun;12(2):119-123. &lt;a href="https://doi.org/10.4103/jpn.JPN_1_17.">doi: 10.4103/jpn.JPN_1_17.&lt;/a>&lt;/p>
&lt;p>Wadhwania R, University of Texas Health Science Center at Houston, Houston, Texas, USA.&lt;/p>
&lt;p>&lt;strong>Dysautonomia&lt;/strong> , dysfunction of the autonomic nervous system, presents with heterogeneous clinical features from an imbalanced regulation of the sympathetic and parasympathetic nervous systems. Low Vitamin D levels can explain the heterogeneous clinical features of&lt;/p>
&lt;ul>
&lt;li>
&lt;p>migraine headaches,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>cardiac and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>gastrointestinal dysfunction, and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>oxidative stress&lt;/p></description></item><item><title>Alzheimer’s, Parkenson’s, and Multiple Sclerosis – vitamin D may prevent and treat</title><link>/posts/alzheimers-parkensons-and-multiple-sclerosis-vitamin-d-may-prevent-and-treat.html</link><pubDate>Thu, 07 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/alzheimers-parkensons-and-multiple-sclerosis-vitamin-d-may-prevent-and-treat.html</guid><description/></item><item><title>Vitamin D and Multiple Sclerosis, Alzheimer's, Parkinson's ,Dementia, and ALS - review</title><link>/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review.html</link><pubDate>Thu, 23 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review.html</guid><description/></item><item><title>Multiple Sclerosis, Alzheimer’s and Parkinson’s need more than 30 ng of Vitamin D – review</title><link>/posts/multiple-sclerosis-alzheimers-and-parkinsons-need-more-than-30-ng-of-vitamin-d-review.html</link><pubDate>Tue, 21 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-alzheimers-and-parkinsons-need-more-than-30-ng-of-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases&lt;/strong>&lt;/p>
&lt;p>EPMA Journal Nov 2017 &lt;a href="https://doi.org/10.1007/s13167-017-0120-8">https://doi.org/10.1007/s13167-017-0120-8&lt;/a>&lt;/p>
&lt;p>    (EPMA Journal is a journal of predictive, preventive and personalized medicine)&lt;/p>
&lt;p>Priscilla Koduah 	• Friedemann Paul • Jan-Markus Dorr&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>Low vitamin D prevents and treats each disease&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review">Vitamin D and Multiple Sclerosis, Alzheimer&amp;rsquo;s, Parkinson&amp;rsquo;s ,Dementia, and ALS - review Nov 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-alzheimers-cognition-and-vitamin-d">Overview Alzheimer&amp;rsquo;s-Cognition and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-parkinsons-and-vitamin-d">Overview Parkinson&amp;rsquo;s and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p></description></item><item><title>Nerve growth and survival depends on BDNF (Brain-Derived Neurotrophic Factor), which is associated with Vitamin D</title><link>/posts/nerve-growth-and-survival-depends-on-bdnf-brain-derived-neurotrophic-factor-whic--with-vitamin-d.html</link><pubDate>Sun, 19 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/nerve-growth-and-survival-depends-on-bdnf-brain-derived-neurotrophic-factor-whic--with-vitamin-d.html</guid><description>&lt;h4 id="in-vitamindwiki">In VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/beneficial-action-of-resveratrol-how-and-why-bndf-etc">Beneficial action of resveratrol: How and why (BNDF, etc.)– Feb 2016&lt;/a> in VitaminDWiki&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/stressors-as-a-fetus-or-child-can-cause-health-problems-in-adult-perhaps-via-epigenetics">Stressors as a fetus or child can cause health problems in adult (perhaps via epigenetics) – Dec 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/more-depression-associated-with-more-dementia-in-seniors-vitamin-d-not-mentioned">More depression associated with more dementia in seniors (vitamin D not mentioned) – July 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/omega-3-vitamin-d-and-other-nutrients-decrease-mental-health-problems">Omega-3, Vitamin D, and other nutrients decrease mental health problems – March 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h4 id="vitamindwiki-is-accumulating-references">VitaminDWiki is accumulating references&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.naturalstacks.com/blogs/news/76618565-why-bdnf-is-miracle-gro-for-your-brain">Why BDNF Is Miracle-Gro For Your Brain&lt;/a> July 2017&lt;/p></description></item><item><title>Parkinson’s patients – 41 percent now supplement with Vitamin D</title><link>/posts/parkinsons-patients-41-percent-now-supplement-with-vitamin-d.html</link><pubDate>Thu, 09 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/parkinsons-patients-41-percent-now-supplement-with-vitamin-d.html</guid><description>&lt;h4 id="parkinsons-survey-finds-strong-adherence-to-medicines-depression-higher-among-menhttpsparkinsonsnewstodaycom20171109a-patient-centered-view-of-parkinsons">&lt;a href="https://parkinsonsnewstoday.com/2017/11/09/a-patient-centered-view-of-parkinsons/">Parkinson’s Survey Finds Strong Adherence to Medicines, Depression Higher Among Men&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Reporting on survey with over 5,000 responses to questions about the daily challenges of life with PD.&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/pd-patient-report-2017.pdf">Download the survey infographic from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Omega-3 found to treat Alzheimer’s and Parkinson’s in animals</title><link>/posts/omega-3-found-to-treat-alzheimers-and-parkinsons-in-animals.html</link><pubDate>Sun, 01 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/omega-3-found-to-treat-alzheimers-and-parkinsons-in-animals.html</guid><description/></item><item><title>The End of Alzheimer's and Dementia if adjust Vitamin D, B-12, Iron, Omega-3, etc.</title><link>/posts/the-end-of-alzheimers-and-dementia-if-adjust-vitamin-d-b-12-iron-omega-3-etc.html</link><pubDate>Sun, 27 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/the-end-of-alzheimers-and-dementia-if-adjust-vitamin-d-b-12-iron-omega-3-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#end-of-alzheimers-books-publications-videos-web---dale-bredesen">End of Alzheimer&amp;rsquo;s books. publications, videos, web - Dale Bredesen&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#recode-the-reversal-of-cognitive-decline--mercola-2017">ReCODE: The Reversal of Cognitive Decline = Mercola 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4-alzheimers-subtypes">4 Alzheimer’s Subtypes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alzheimers-screening-tests">Alzheimer’s Screening Tests&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#annual-summit-on-alzheimers-prevention-june-2023-etc">Annual summit on Alzheimer&amp;rsquo;s prevention (June 2023, etc.)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nov-2021-email-from-end-of-alz-organization----details-and-pricing">Nov 2021 email from End of Alz organization - details and pricing&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bredesen-protocol-and-span-stylecolor00fparkinsonsspan">Bredesen protocol and &lt;span style="color:#00F;">Parkinson&amp;rsquo;s&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="end-of-alzheimers-books-publications-videos-web---dale-bredesen">End of Alzheimer&amp;rsquo;s books. publications, videos, web - Dale Bredesen&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/alzheimers-is-now-optional-dr-bredesen-video-and-transcript">Alzheimer’s Is Now Optional - Dr. Bredesen video and transcript Sept 2023&lt;/a>&lt;/p></description></item><item><title>Off Topic: Some disabled people (MS, Parkinson, blind, deaf etc) are using second life</title><link>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</guid><description>&lt;h4 id="great-articlehttpsbackchannelcomfirst-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9pia9rk6v620">&lt;a href="https://backchannel.com/first-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9#.pia9rk6v6%20">Great article&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>800,000 users each month&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Second Life has many disability groups&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The Virtual Ability group has thousand members, and hosts a dozen or so events per week, including games, live piano concerts, dance parties and self-help workshops&lt;/p>
&lt;/li>
&lt;li>
&lt;p>For some of the people the experiencing of a virtual ability results in an improved ability in real life&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h3 id="httpsecondlifecomhttpsecondlifecom">&lt;a href="http://secondlife.com/">http://secondlife.com/&lt;/a>&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/second-life.jpg" alt="image" width="500"></description></item><item><title>Pooping takes much longer if low vitamin D and have Parkinson’s Disease</title><link>/posts/pooping-takes-much-longer-if-low-vitamin-d-and-have-parkinsons-disease.html</link><pubDate>Thu, 29 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/pooping-takes-much-longer-if-low-vitamin-d-and-have-parkinsons-disease.html</guid><description>&lt;h4 id="low-serum-vitamin-d-levels-may-contribute-to-gastric-dysmotility-in-de-novo-parkinsons-disease">Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson&amp;rsquo;s Disease.&lt;/h4>
&lt;p>Neurodegener Dis. 2016;16(3-4):199-205. &lt;a href="https://doi.org/10.1159/000441917.">doi: 10.1159/000441917.&lt;/a> Epub 2016 Jan 7.&lt;/p>
&lt;p>Kwon KY1, Jo KD, Lee MK, Oh M, Kim EN, Park J, Kim JS, Youn J, Oh E, Kim HT, Oh MY, Jang W.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>14 seconds No PD&lt;/p>
&lt;p>19 seconds PD, not low vitamin D&lt;/p>
&lt;p>33 seconds PD and associated with low Vitamin D&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Wonder if poop-time is also increased for those with low D but without PD?&lt;/p></description></item><item><title>Parkinson's disease cognitive decline associated with poor Vitamin D receptor</title><link>/posts/parkinsons-disease-cognitive-decline-associated-with-poor-vitamin-d-receptor.html</link><pubDate>Sat, 12 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-cognitive-decline-associated-with-poor-vitamin-d-receptor.html</guid><description>&lt;h4 id="vitamin-d-receptor-gene-polymorphisms-and-cognitive-decline-in-parkinsons-disease">Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson&amp;rsquo;s disease.&lt;/h4>
&lt;p>J Neurol Sci. 2016 Nov 15;370:100-106. &lt;a href="https://doi.org/10.1016/j.jns.2016.09.013.">doi: 10.1016/j.jns.2016.09.013.&lt;/a> Epub 2016 Sep 11.&lt;/p>
&lt;p>Gatto NM1, Paul KC2, Sinsheimer JS3, Bronstein JM4, Bordelon Y4, Rausch R4, Ritz B5.&lt;/p>
&lt;p>We and others have suggested that vitamin D receptor gene (VDR) polymorphisms influence susceptibility for Parkinson&amp;rsquo;s disease (PD), Alzheimer&amp;rsquo;s disease (AD), mild cognitive impairment (MCI) or overall cognitive functioning. Here we examine VDR polymorphisms and cognitive decline in patients with PD. Non-Hispanic Caucasian PD patients (n=190) in the Parkinson Environment Gene (PEG) study were successfully genotyped for seven VDR polymorphisms. Cognitive function was assessed with the Mini-Mental State Exam (MMSE) at baseline and at a maximum of three follow-up exams. Using repeated-measures regression we assessed associations between VDR SNP genotypes and change in MMSE longitudinally. PD cases were on average 67.4 years old at diagnosis and were followed for an average of 7.1 years into disease.&lt;/p></description></item><item><title>Parkinson’s disease 2 times less likely if get 2 hours of daily sun</title><link>/posts/parkinsons-disease-2-times-less-likely-if-get-2-hours-of-daily-sun.html</link><pubDate>Mon, 07 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-2-times-less-likely-if-get-2-hours-of-daily-sun.html</guid><description>&lt;h3 id="sunlight-and-vitamin-d-protect-against-parkinsons-diseasehttpergo-logcomsunlight-and-vitamin-d-protect-against-parkinson-s-diseasehtml20">&lt;a href="http://ergo-log.com/sunlight-and-vitamin-d-protect-against-parkinson-s-disease.html%20">Sunlight and vitamin D protect against Parkinson&amp;rsquo;s disease&lt;/a>&lt;/h3>
&lt;ul>
&lt;li>“People who spend two hours a day outside are two times less likely to develop Parkinson&amp;rsquo;s disease than people who only spend an hour or less outside,”&lt;/li>
&lt;/ul>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:650px">
&lt;p>&lt;strong>Reminder:&lt;/strong> The benefit of sun comes only from 10 AM to 3 PM during the summer&lt;/p>
&lt;p>    When your shadow is as long as you are you get 1/2 of much vitamin D&lt;/p>
&lt;p>&lt;strong>Reminder:&lt;/strong> Far more vitamin D is generated when more skin is exposed and lying down&lt;/p></description></item><item><title>Parkinson’s risk increased 2 to 7 times depending on Vitamin D Receptor</title><link>/posts/parkinsons-risk-increased-2-to-7-times-depending-on-vitamin-d-receptor.html</link><pubDate>Fri, 23 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/parkinsons-risk-increased-2-to-7-times-depending-on-vitamin-d-receptor.html</guid><description>&lt;h4 id="see-also-web">See also web&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/27772736">Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson&amp;rsquo;s disease&lt;/a>&lt;/p>
&lt;ul>
&lt;li>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vdr-parkinson-s-2016.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson’s disease - Sept 2020&lt;/p>
&lt;ul>
&lt;li>&lt;a href="https://doi.org/10.1186/s40035-020-00213-2">https://doi.org/10.1186/s40035-020-00213-2&lt;/a> FREE PDF&lt;/li>
&lt;/ul>
&lt;/li>
&lt;/ul></description></item><item><title>Parkinson's Disease associations with Vitamin D Receptor and GC gene</title><link>/posts/parkinsons-disease-associations-with-vitamin-d-receptor-and-gc-gene.html</link><pubDate>Sat, 11 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-associations-with-vitamin-d-receptor-and-gc-gene.html</guid><description/></item><item><title>Dopamine increased with vitamin D supplementation (in rats)</title><link>/posts/dopamine-increased-with-vitamin-d-supplementation-in-rats.html</link><pubDate>Tue, 26 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/dopamine-increased-with-vitamin-d-supplementation-in-rats.html</guid><description>&lt;h4 id="the-vitamin-d-content-of-a-high-fat-diet-modulates-brain-reward-neurochemistry">The Vitamin D Content of a High-Fat Diet Modulates Brain Reward Neurochemistry&lt;/h4>
&lt;p>The FASEB Journal, vol. 30 no. 1 Supplement lb202 , April 2016&lt;/p>
&lt;p>Ruslan Kubant1, Diptendu Chatterjee1, Emanuela Pannia1 and G. Harvey Anderson1,2&lt;/p>
&lt;p>1Nutritional Sciences, University of Toronto, Toronto, ON, Canada&lt;/p>
&lt;p>2Physiology, University of Toronto, Toronto, ON, Canada&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>Rats on high fat diet (60% of calories)&lt;/p>
&lt;p>Age 3 weeks to 17 weeks&lt;/p>
&lt;p>Compare 7,000 IU vs 1000 IU of Vitamin D per kilogram of feed&lt;/p></description></item><item><title>Low levels of Vitamin D associated with Parkinson’s Disease – editorial</title><link>/posts/low-levels-of-vitamin-d-associated-with-parkinsons-disease-editorial.html</link><pubDate>Tue, 19 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/low-levels-of-vitamin-d-associated-with-parkinsons-disease-editorial.html</guid><description>&lt;h4 id="serum-vitamin-d-and-risk-of-parkinsons-disease--editorial">Serum vitamin D and risk of Parkinson&amp;rsquo;s disease -Editorial&lt;/h4>
&lt;p>G. Webster Ross MD1,2,3,4,*, Helen Petrovitch MD1,2,4 and Robert D. Abbott PhD2,4,5&lt;/p>
&lt;p>Movement Disorders, Article first published online: 19 APR 2016, DOI: 10.1002/mds.26639&lt;/p>
&lt;p>© 2016 International Parkinson and Movement Disorder Society&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://onlinelibrary.wiley.com/doi/10.1002/mds.26639/pdf">Publisher rents PDF for $6&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Study in current issue did not find relationship between Parkinson’s Disease and vitamin D&lt;/p>
&lt;p>They speculated that it was probably because the current study only had 32% deficient, whereas previous (successful) study had 75% deficient.&lt;/p></description></item><item><title>Off topic - Parkinson’s Disease changes gut bacteria</title><link>/posts/off-topic-parkinsons-disease-changes-gut-bacteria.html</link><pubDate>Wed, 20 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/off-topic-parkinsons-disease-changes-gut-bacteria.html</guid><description>&lt;h5 id="gut-microbiota-are-related-to-parkinsons-disease-and-clinical-phenotype">Gut microbiota are related to Parkinson&amp;rsquo;s disease and clinical phenotype&lt;/h5>
&lt;p>Movement Disorders, Volume 30, Issue 3, pages 350–358, March 2015, DOI: 10.1002/mds.26069&lt;/p>
&lt;p>Filip Scheperjans MD, PhD1,*, Velma Aho MSc, BA2, Pedro A. B. Pereira MSc2, Kaisa Koskinen PhD2, Lars Paulin MSc2, Eero Pekkonen MD, PhD1, Elena Haapaniemi MD, PhD1, Seppo Kaakkola MD, PhD1, Johanna Eerola-Rautio MD, PhD1, Marjatta Pohja MD, PhD1, Esko Kinnunen MD, PhD3, Kari Murros MD, PhD1 and Petri Auvinen PhD2&lt;/p></description></item><item><title>Parkinson’s Disease systematic review finds association with low vitamin D</title><link>/posts/parkinsons-disease-systematic-review-finds-association-with-low-vitamin-d.html</link><pubDate>Wed, 13 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-systematic-review-finds-association-with-low-vitamin-d.html</guid><description>&lt;h4 id="systematic-review-of-the-relationship-between-vitamin-d-and-parkinsons-disease">Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease&lt;/h4>
&lt;p>Journal of Parkinson&amp;rsquo;s Disease, Preprint, pp. 1-9, 2016, DOI: 10.3233/JPD-150615&lt;/p>
&lt;p>Rimmelzwaan, Lisanne M.a | van Schoor, Natasja M.b | Lips, Paula | Berendse, Henk W.c | Eekhoff, Elisabeth M.W.a; *&lt;/p>
&lt;p>&lt;span>[a]&lt;/span> Department of Internal Medicine section Endocrinology, VU University Medical Centre, Amsterdam, The Netherlands |&lt;/p>
&lt;p>&lt;span>[b]&lt;/span> Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands |&lt;/p></description></item><item><title>Risk of Parkinson disease associated with low vitamin D3 (2.6X) or low D2</title><link>/posts/risk-of-parkinson-disease-associated-with-low-vitamin-d3-26x-or-low-d2.html</link><pubDate>Sun, 10 May 2015 00:00:00 +0000</pubDate><guid>/posts/risk-of-parkinson-disease-associated-with-low-vitamin-d3-26x-or-low-d2.html</guid><description>&lt;h4 id="vitamin-d-from-different-sources-is-inversely-associated-with-parkinson-disease">Vitamin D from different sources is inversely associated with Parkinson disease&lt;/h4>
&lt;p>Movement Disorders, Volume 30, Issue 4, pages 560–566, April 2015, DOI: 10.1002/mds.26117&lt;/p>
&lt;p>Liyong Wang PhD1,2,*, Marian L. Evatt MD3, Lizmarie G. Maldonado MSPH1, William R. Perry MPH1, James C. Ritchie PhD4, Gary W. Beecham PhD1,2, Eden R. Martin PhD1,2, Jonathan L. Haines PhD5, Margaret A. Pericak-Vance PhD1,2, Jeffery M. Vance MD, PhD1,2 and William K. Scott PhD1,2 &lt;a href="mailto:bscott@med.miami.edu">bscott@med.miami.edu&lt;/a>&lt;/p>
&lt;p>1John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA&lt;/p></description></item><item><title>Brains of seniors had 60 percent more white matter abnormalities if low vitamin D</title><link>/posts/brains-of-seniors-had-60-percent-more-white-matter-abnormalities-if-low-vitamin-d.html</link><pubDate>Wed, 25 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/brains-of-seniors-had-60-percent-more-white-matter-abnormalities-if-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-and-white-matter-abnormalities-in-older-adults-a-quantitative-volumetric-analysis-of-brain-mri">Vitamin D and white matter abnormalities in older adults: A quantitative volumetric analysis of brain MRI&lt;/h4>
&lt;p>Experimental Gerontology, Volume 63, March 2015, Pages 41–47. doi:10.1016/j.exger.2015.01.049&lt;/p>
&lt;p>Cédric Annweilera, b, c, &lt;a href="mailto:CeAnnweiler@chu-angers.fr">CeAnnweiler@chu-angers.fr&lt;/a>, Robert Barthac, Spyridon N. Karrasd, Jennifer Gautierb, Frédéric Rochee, Olivier Beaucheta, b, f&lt;/p>
&lt;p>a Department of Geriatric Medicine, Angers University Hospital; UPRES EA4638, University of Angers, UNAM, France&lt;/p>
&lt;p>b Research Center on Autonomy and Longevity (CeRAL), Angers, France&lt;/p>
&lt;p>c Robarts Research Institute, Department of Medical Biophysics, Schulich School of Medicine and Dentistry, the University of Western Ontario, London, ON, Canada&lt;/p></description></item><item><title>20 X more Parkinson's and 100X more Autism with GMO soy in China</title><link>/posts/20-x-more-parkinsons-and-100x-more-autism-with-gmo-soy-in-china.html</link><pubDate>Thu, 08 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/20-x-more-parkinsons-and-100x-more-autism-with-gmo-soy-in-china.html</guid><description>&lt;h4 id="in-20-years">In 20 years&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/gm-soy-china.jpg" alt="image">
&lt;p>&lt;a href="http://sustainablepulse.com/2014/05/11/must-face-harm-caused-imported-gm-soybeans-1-3-billion-chinese-people/#.VzIS1IQrLIV">Click here for similar/same report&lt;/a>&lt;/p>
&lt;p>&lt;a href="http://www.momsacrossamerica.com/china_and_gmo_double_standard">Note: no GMO for children of party officials, but other Chinese children get GMO foods&lt;/a>&lt;/p>
&lt;h3 id="seneff-nov-2014httppeoplecsailmiteduseneff-winston-price-conference">&lt;a href="http://people.csail.mit.edu/seneff/">Seneff Nov 2014&lt;/a> Winston Price Conference&lt;/h3>
&lt;h3 id="note-china-baned-gmo-imported-foods-2014">Note: China baned GMO imported foods 2014?&lt;/h3>
&lt;p>&lt;strong>Huge decline of exports of corn,soy, etc from US, Argintina, etc. to China&lt;/strong>&lt;/p>
&lt;p>Actually, the GMO is not the problem exactly, but Roundup.&lt;/p>
&lt;hr>
&lt;h3 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/autism-1-in-40-children-in-the-us-as-of-2016">Autism – 1 in 40 children in the US (as of 2016) – Nov 2018&lt;/a>&lt;/p></description></item><item><title>2X more Parkinson's disease if modified vitamin D receptor genes – meta-analysis</title><link>/posts/2x-more-parkinsons-disease-if-modified-vitamin-d-receptor-genes-meta-analysis.html</link><pubDate>Sat, 30 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/2x-more-parkinsons-disease-if-modified-vitamin-d-receptor-genes-meta-analysis.html</guid><description/></item><item><title>Parkinson's and Alzheimer's: associations with vitamin D receptor genes and race – meta-analysis</title><link>/posts/parkinsons-and-alzheimers-associations-with-vitamin-d-receptor-genes-and-race-meta-analysis.html</link><pubDate>Sat, 12 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-and-alzheimers-associations-with-vitamin-d-receptor-genes-and-race-meta-analysis.html</guid><description/></item><item><title>Parkinson’s Disease – no association found with changes in Vitamin D genes – meta-analysis</title><link>/posts/parkinsons-disease-no-association-found-with-changes-in-vitamin-d-genes-meta-analysis.html</link><pubDate>Tue, 01 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-no-association-found-with-changes-in-vitamin-d-genes-meta-analysis.html</guid><description>&lt;h4 id="association-between-vitamin-d-receptor-gene-polymorphisms-and-susceptibility-to-parkinsons-disease-a-meta-analysis">Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson&amp;rsquo;s disease: A meta-analysis&lt;/h4>
&lt;p>Neuroscience Letters, online 30 June 2014, DOI: 10.1016/j.neulet.2014.06.051&lt;/p>
&lt;p>Zhang Zitenga, 1, He Yichuanb, 1, Ma Xiujuana, Li Dianyoub, Lu Guocaia,&lt;/p>
&lt;p>Corresponding author. 800 Xiangyin Road, Yangpu District, Shanghai, P.R. China, 200433. Tel.: +8615002178993. &lt;a href="mailto:newdrug@smmu.edu.cn">newdrug@smmu.edu.cn&lt;/a>&lt;/p>
&lt;p>1 These two authors contributed equally to this work.&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>This meta-analysis focused on the association between the vitamin d receptor gene polymorphism and the PD risk.&lt;/p></description></item><item><title>Swallowing problems (dysphagia): in Multiple Sclerosis and Parkinson’s Disease (perhaps low vitamin D)</title><link>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</link><pubDate>Tue, 01 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</guid><description>&lt;ol>
&lt;li>July 2014: Noticed &lt;a href="http://www.slideshare.net/gavingiovannoni/dysphagia-survey-results?qid=fe376289-23e5-4072-a032-eb3680b23786&amp;amp;v=qf1&amp;amp;b=&amp;amp;from_search=4">survey on dysphagia and MS&lt;/a> by a researcher I am following concerning MS and Vitamin D&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>Posting is attached at bottom of this page&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Had to look up the definition of dysphagia&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=dysphagia+%22multiple+sclerosis%22">Searched PubMed for dysphagia &amp;ldquo;multiple sclerosis&amp;rdquo;&lt;/a> 101 items&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Dysphagia+%22Parkinson%27s+disease%22">Searched PubMed for Dysphagia &amp;ldquo;Parkinson&amp;rsquo;s disease&amp;rdquo;&lt;/a> 336 items as of July 2014&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Increasing report of dysphagia and MS (which might be indicative of decreasing levels of vitamin D)&lt;/p></description></item><item><title>Hypothesis: Early onset Parkinson's (LRRK2) can be prevented with vitamin D</title><link>/posts/hypothesis-early-onset-parkinsons-lrrk2-can-be-prevented-with-vitamin-d.html</link><pubDate>Tue, 03 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-early-onset-parkinsons-lrrk2-can-be-prevented-with-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;/li>
 &lt;li>&lt;a href="#references-on-vitamindwiki">References on VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h5 id="trialexperiment-details">Trial/Experiment details&lt;/h5>
&lt;p>Recruit from LRRK2 people identified by 23andMe who indicated that they could be contacted (typically 80%)&lt;/p>
&lt;p>Since the high doses of vitamin D are individually adjusted this cannot be a standard RCT trial.&lt;/p>
&lt;p>Also, each participant must have a local doctor who will agree to oversee the trial (Dr. will be paid)&lt;/p>
&lt;p>Click on plus signs in each section to see details&lt;/p></description></item><item><title>Parkinson's disease and LRRK2 gene</title><link>/posts/parkinsons-disease-and-lrrk2-gene.html</link><pubDate>Mon, 02 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-lrrk2-gene.html</guid><description>&lt;p>Note: &lt;strong>Sergey Brin has the LRRK2 gene mutation which is associated with 50% chance of his getting early-onset Parkinson’s Disease in the next 10 years&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#lrrk2-and-neuroinflammation-partners-in-crime-in-parkinsons-disease--march-2014-pdf-attached">LRRK2 and neuroinflammation: partners in crime in Parkinson&amp;rsquo;s disease? – March 2014 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-kinase-lrrk2-mutated-in-parkinsons-disease-is-required-for-vitamin-d3-and-phosphate-metabolism--june-2013">THE KINASE LRRK2, MUTATED IN PARKINSONS DISEASE, IS REQUIRED FOR VITAMIN D3 AND PHOSPHATE METABOLISM = June 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetic-insights-into-sporadic-parkinsons-disease-pathogenesis-dec-2013-pdf-attached">Genetic insights into sporadic Parkinson&amp;rsquo;s disease pathogenesis. Dec 2013 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review-of-early-onset-pd-and-gene-mutations--oct-2012">Review of Early onset PD and gene mutations – Oct 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-genetics-tells-us-about-the-causes-and-mechanisms-of-parkinsons-disease--oct-2011-pdf-attached">What genetics tells us about the causes and mechanisms of Parkinson&amp;rsquo;s disease. – Oct 2011 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-genetics-tells-us-about-the-causes-decreased-in-rats-with-curcumin-lrrk2-gene--jan-2010">What genetics tells us about the causes decreased in rats with curcumin (LRRK2 gene) – Jan 2010&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#history-of-genetics-and-pd-medscape-2012">History of Genetics and PD: Medscape 2012&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pmid2019879924">PMID:%2019879924&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#parkinsons-disease-relationship-to-vitamin-dpostsparkinsons-disease-relationship-to-vitamin-d">&lt;a href="/posts/parkinsons-disease-relationship-to-vitamin-d">Parkinson’s Disease relationship to Vitamin D&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lrrk2-at-genecards---extensive-details">LRRK2 at GeneCards - extensive details&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="lrrk2-and-neuroinflammation-partners-in-crime-in-parkinsons-disease--march-2014-pdf-attached">LRRK2 and neuroinflammation: partners in crime in Parkinson&amp;rsquo;s disease? – March 2014 PDF attached&lt;/h3>
&lt;p>J Neuroinflammation. 2014 Mar 21;11:52. &lt;a href="https://doi.org/10.1186/1742-2094-11-52.">doi: 10.1186/1742-2094-11-52.&lt;/a>&lt;/p></description></item><item><title>Parkinson’s disease 2X more likely if low Vitamin D – meta-analysis</title><link>/posts/parkinsons-disease-2x-more-likely-if-low-vitamin-d-meta-analysis.html</link><pubDate>Thu, 22 May 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-2x-more-likely-if-low-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-status-and-parkinsons-disease-a-systematic-review-and-meta-analysis">Vitamin D status and Parkinson’s disease: a systematic review and meta-analysis&lt;/h4>
&lt;p>Neurological Sciences, May 2014&lt;/p>
&lt;p>Zheng Lv, Huiping Qi, Le Wang, Xiaoxue Fan, Fei Han, Hong Wang, Sheng Bi &lt;a href="mailto:13224510036@163.com">13224510036@163.com&lt;/a>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Rehabilitation, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, the Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>To estimate the associations between vitamin D status and Parkinson’s disease (PD). We searched electronic databases of the human literature in PubMed, EMBASE and the Cochrane Library up to February, 2014 using the following keywords: ‘vitamin D’ or ‘25(OH)D’ and ‘status’ or ‘deficiency’ or ‘insufficiency’ and ‘Parkinson’s disease’. A systematic review and meta-analysis were conducted on observational studies that reported the association between blood vitamin D levels and PD. Seven studies met the inclusion criteria. 1,008 patients and 4,536 controls were included.&lt;/p></description></item><item><title>Parkinson's disease severity association with level of vitamin D – 2013</title><link>/posts/parkinsons-disease-severity-association-with-level-of-vitamin-d-2013.html</link><pubDate>Tue, 29 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-severity-association-with-level-of-vitamin-d-2013.html</guid><description>&lt;h3 id="25-hydroxyvitamin-d-and-severity-of-parkinsons-disease">25-hydroxyvitamin d and severity of Parkinson&amp;rsquo;s disease.&lt;/h3>
&lt;p>Int J Endocrinol. 2013;2013:689149. &lt;a href="https://doi.org/10.1155/2013/689149.">doi: 10.1155/2013/689149.&lt;/a> Epub 2013 Jul 17.&lt;/p>
&lt;p>Chitsaz A1, Maracy M, Basiri K, Izadi Boroujeni M, Tanhaei AP, Rahimi M, Meamar R.&lt;/p>
&lt;p>Introduction. A role for vitamin D deficiency in Parkinson&amp;rsquo;s disease (PD) has recently been proposed. Given the growing body of evidence for the association of vitamin D with several neurodegenerative disorders and unavailability of any published study in the Middle East, the present study is aimed to determine the associations of circulating 25-hydroxyvitamin D (25OHD) levels with the severity of PD in an Iranian sample.&lt;/p></description></item><item><title>Parkinson's disease and vitamin D – review finds promising indications</title><link>/posts/parkinsons-disease-and-vitamin-d-review-finds-promising-indications.html</link><pubDate>Wed, 02 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-vitamin-d-review-finds-promising-indications.html</guid><description>&lt;h2 id="a-review-of-vitamin-d-and-parkinsons-disease">A review of vitamin D and Parkinson&amp;rsquo;s disease.&lt;/h2>
&lt;p>Maturitas. 2014 Mar 5. pii: S0378-5122(14)00063-2. &lt;a href="https://doi.org/10.1016/j.maturitas.2014.02.012.">doi: 10.1016/j.maturitas.2014.02.012.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Peterson AL.&lt;/p>
&lt;p>The role of vitamin D in bone health has been known for over a century. More recent research has suggested that vitamin D may play a role in the muscular, immune, endocrine, and central nervous systems. Animal research suggests that vitamin D may have some protective effects against toxic insults that are known to damage dopamine cells, the primary cells to degenerate in PD. Persons with PD tend to have lower vitamin D levels than persons of similar ages without PD. Vitamin D levels are generally associated with bone mineral density (BMD) in persons with PD, but simply giving vitamin D does not appear to improve BMD. Results of genetic studies examining polymorphism of the vitamin D receptor and PD risk, severity, or age at onset have shown variable results, with FokI CC seeming to possibly carry some increased risk of PD. Amount of sun exposure and vitamin D levels in earlier life may influence the risk of developing PD. Cross-sectional research suggests a relationship between vitamin D levels and severity of PD symptoms. A single intervention study did show some improvement in PD with vitamin D supplementation. Vitamin D may have effects on PD symptoms and perhaps even on the risk of disease development or disease progression. More well designed intervention studies are needed to confirm the effect of vitamin D on PD symptoms. Human neuroprotection studies are needed, but probably not feasible until better biomarkers are established.&lt;/p></description></item><item><title>Parkinson's patients having more vitamin D had better balance control</title><link>/posts/parkinsons-patients-having-more-vitamin-d-had-better-balance-control.html</link><pubDate>Sat, 08 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-patients-having-more-vitamin-d-had-better-balance-control.html</guid><description>&lt;h3 id="the-relationship-between-balance-control-and-vitamin-d-in-parkinsons-disease-a-pilot-study">The relationship between balance control and vitamin D in Parkinson&amp;rsquo;s disease-a pilot study.&lt;/h3>
&lt;p>Mov Disord. 2013 Jul;28(8):1133-7. &lt;a href="https://doi.org/10.1002/mds.25405.">doi: 10.1002/mds.25405.&lt;/a> Epub 2013 Apr 2.&lt;/p>
&lt;p>Peterson AL1, Mancini M, Horak FB.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Balance problems and falls are a major source of morbidity and mortality in patients with Parkinson&amp;rsquo;s disease.&lt;/p>
&lt;p>Vitamin D supplementation reduces falls and sway in neurologically intact elderly fallers, but effects in Parkinson&amp;rsquo;s disease are not established.&lt;/p>
&lt;p>METHODS:&lt;/p>
&lt;p>To study this relationship and select outcome measures for a vitamin D intervention study, balance function and vitamin D concentration were quantified in a series of Parkinson&amp;rsquo;s patients in a cross-sectional, observational study. Participants underwent a battery of 5 balance tests.&lt;/p></description></item><item><title>Central Nervous System helped by Vitamin D – Review – 2013</title><link>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</guid><description>&lt;h2 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h2>
&lt;p>Pharmacological Reports 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw,&lt;/p>
&lt;p>Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>Parkinsons' disease and MRI white matter in brain</title><link>/posts/parkinsons-disease-and-mri-white-matter-in-brain.html</link><pubDate>Tue, 28 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-mri-white-matter-in-brain.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#white-matter-hyperintensities-in-parkinsons-disease-do-they-explain-the-disparity-between-the-postural-instability-gait-difficulty-and-tremor-dominant-subtypes-jan-2013">White matter hyperintensities in Parkinson&amp;rsquo;s disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? Jan 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cerebral-white-matter-hyperintensity-in-parkinsons-disease-a-major-risk-factor-for-mild-cognitive-impairment---july-2013">Cerebral white matter hyperintensity in Parkinson&amp;rsquo;s disease: a major risk factor for mild cognitive impairment. - July 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#white-matter-hyperintensities-successfully-differentiate-parkinsons-disease-patients-with-and-without-cognitive-impairment-feb-2013">White Matter Hyperintensities Successfully Differentiate Parkinson&amp;rsquo;s Disease Patients with and without Cognitive Impairment Feb 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-white-matter-in-vitamindwiki">See also white matter in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="white-matter-hyperintensities-in-parkinsons-disease-do-they-explain-the-disparity-between-the-postural-instability-gait-difficulty-and-tremor-dominant-subtypes-jan-2013">White matter hyperintensities in Parkinson&amp;rsquo;s disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? Jan 2013&lt;/h4>
&lt;p>PLoS One. 2013;8(1):e55193. &lt;a href="https://doi.org/10.1371/journal.pone.0055193.">doi: 10.1371/journal.pone.0055193.&lt;/a> Epub 2013 Jan 31.&lt;/p></description></item><item><title>Parkinson's Disease – better memory and less depression with higher levels of vitamin D</title><link>/posts/parkinsons-disease-better-memory-and-less-depression-with-higher-levels-of-vitamin-d.html</link><pubDate>Wed, 22 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-better-memory-and-less-depression-with-higher-levels-of-vitamin-d.html</guid><description>&lt;h2 id="memory-mood-and-vitamin-d-in-persons-with-parkinsons-disease">Memory, Mood, and Vitamin D in Persons with Parkinson&amp;rsquo;s Disease&lt;/h2>
&lt;p>Journal of Parkinson&amp;rsquo;s Disease; Volume 3, Number 4 / 2013, Pages 547-555&lt;/p>
&lt;p>Amie L. Peterson 1, 5, Charles Murchison 5, Cyrus Zabetian 2, 3, 6, James B. Leverenz 2, 3, 4, 6, G. Stennis Watson 3, 6, Thomas Montine 6, Natasha Carney 1, Gene L. Bowman 5, Karen Edwards 6, Joseph F. Quinn 1, 5&lt;/p>
&lt;p>1 Parkinson&amp;rsquo;s Disease Research, Education &amp;amp; Clinical Center (PADRECC), Portland VA Medical Center, Portland, OR, USA&lt;/p></description></item><item><title>Parkinson’s Disease relationship to Vitamin D</title><link>/posts/parkinsons-disease-relationship-to-vitamin-d.html</link><pubDate>Sat, 04 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-relationship-to-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#parkinson-disease-low-vitamin-d-and-parkinson-diseasea-causal-conundrum--jan-2014--span-stylecolor00fevattspan">Parkinson disease: Low vitamin D and Parkinson disease—a causal conundrum – Jan 2014 &lt;strong>&lt;span style="color:#00F;">Evatt&lt;/span>&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2-minute-video-by-evatthttpwwwwhscemoryedusoundsciencearchivesevatthtml-2014-4-minute-audio">&lt;a href="http://www.whsc.emory.edu/soundscience/archives/evatt.html">2 minute video by Evatt&lt;/a> 2014? 4 minute audio&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-intervention-trial-by-dr-evatt-for-the-vahttpclinicaltrialsgovct2shownct00571285termnct00571285rank1">&lt;a href="http://clinicaltrials.gov/ct2/show/NCT00571285?term=NCT00571285&amp;amp;rank=1">Clinical Intervention Trial by Dr. Evatt for the VA&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-intervention-trial-at-another-va-locationhttpclinicaltrialsgovct2resultstermnct01119131searchsearch-to-be-completed-2015">&lt;a href="http://clinicaltrials.gov/ct2/results?term=NCT01119131&amp;amp;Search=Search">Clinical Intervention Trial at another VA location&lt;/a> to be completed 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-kinase-lrrk2-mutated-in-parkinsons-disease-is-required-for-vitamin-d3-and-phosphate-metabolism---2013">THE KINASE LRRK2, MUTATED IN PARKINSONS DISEASE, IS REQUIRED FOR VITAMIN D3 AND PHOSPHATE METABOLISM - 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-depletion-does-not-exacerbate-mptp-induced-dopamine-neuron-damage-in-mice--2012--span-stylecolor00fevattspan">25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. – 2012 &lt;strong>&lt;span style="color:#00F;">Evatt&lt;/span>&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#high-prevalence-of-hypovitaminosis-d-status-in-patients-with-early-parkinson-disease--2011--span-stylecolor00fevattspan">High prevalence of hypovitaminosis D status in patients with early Parkinson disease. – 2011 &lt;strong>&lt;span style="color:#00F;">Evatt&lt;/span>&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#parkinson-disease-and-vitamin-d-an-interplay-between-genes-and-the-environment--comment-dec-2011">Parkinson Disease and Vitamin D: An Interplay Between Genes and the Environment? – comment Dec 2011&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#beyond-vitamin-status-is-there-a-role-for-vitamin-d-in-parkinson-disease--2010--span-stylecolor00fevattspan">Beyond vitamin status: is there a role for vitamin d in Parkinson disease? – 2010 &lt;strong>&lt;span style="color:#00F;">Evatt&lt;/span>&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#serum-vitamin-d-and-the-risk-of-parkinson-disease--2010">Serum Vitamin D and the Risk of Parkinson Disease – 2010&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="parkinson-disease-low-vitamin-d-and-parkinson-diseasea-causal-conundrum--jan-2014--span-stylecolor00fevattspan">Parkinson disease: Low vitamin D and Parkinson disease—a causal conundrum – Jan 2014 &lt;strong>&lt;span style="color:#00F;">Evatt&lt;/span>&lt;/strong>&lt;/h4>
&lt;p>Nature Reviews Neurology. 10, 8–9 (2014) doi:10.1038/nrneurol.2013.252&lt;/p></description></item><item><title>Comparison of Alzheimer's Disease and Parkinson's Disease</title><link>/posts/comparison-of-alzheimers-disease-and-parkinsons-disease.html</link><pubDate>Fri, 27 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/comparison-of-alzheimers-disease-and-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#comparing-clinical-profiles-in-alzheimers-disease-and-parkinsons-disease-dementia">Comparing Clinical Profiles in Alzheimer&amp;rsquo;s Disease and Parkinson&amp;rsquo;s Disease Dementia&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#materials-and-methods">Materials and Methods&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#clinical-studies">Clinical Studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#statistical-analysis">Statistical Analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#patients">Patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-baseline-adas-cog-adcs-adl-and-npi-10-data-between-the-ad-and-pdd-patient-populations">Comparison of Baseline ADAS-cog, ADCS-ADL and NPI-10 Data between the AD and PDD Patient Populations&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#acknowledgements">Acknowledgements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#disclosure-statement">Disclosure Statement&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="comparing-clinical-profiles-in-alzheimers-disease-and-parkinsons-disease-dementia">Comparing Clinical Profiles in Alzheimer&amp;rsquo;s Disease and Parkinson&amp;rsquo;s Disease Dementia&lt;/h2>
&lt;p>Dement Geriatr Cogn Disord Extra 2013;3:281-290 Sept 2013&lt;/p>
&lt;p>Martin R. Farlowa Frederick Schmitt b Dag Aarsland c d George T. Grossberg e Monique Somogyi f Xiangyi Mengf&lt;/p></description></item><item><title>Parkinson's and vitamin D</title><link>/posts/parkinsons-and-vitamin-d.html</link><pubDate>Thu, 26 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-and-vitamin-d.html</guid><description>&lt;h4 id="center-for-disease-control-has-found-a-3x-increase-in-pd-deaths-during-the-time-that-vitamin-d-has-been-decreasinghttpwwwcdcgovmmwrpreviewmmwrhtmlmm5506a7htm">&lt;a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5506a7.htm">Center for Disease Control has found a 3X increase in PD deaths during the time that vitamin D has been decreasing&lt;/a>&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/gif/parkinsons-age-adjusted.gif" alt="image"></description></item><item><title>Parkinson’s Disease and the “Sunshine” Vitamin (vitamin D)</title><link>/posts/parkinsons-disease-and-the-sunshine-vitamin-vitamin-d.html</link><pubDate>Thu, 26 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-the-sunshine-vitamin-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biology-of-the-sunshine-vitamin">Biology of the &amp;ldquo;Sunshine&amp;rdquo; Vitamin&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#prevalence-of-hypovitaminosis-d">Prevalence of Hypovitaminosis D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-and-the-sunshine-vitamin-the-relationship">PD and the &amp;ldquo;Sunshine&amp;rdquo; Vitamin: The Relationship&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-and-vitamin-d-biological-evidence-for-a-relationship">PD and Vitamin D: Biological Evidence for a Relationship&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-inducible-nitric-oxide-synthase--peroxynitrite--and-glutathione">Vitamin D, Inducible Nitric Oxide Synthase, &lt;strong>peroxynitrite&lt;/strong> and Glutathione&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-the-vitamin-d-receptor-and-glial-derived-neurotrophic-factor">Vitamin D, the Vitamin D Receptor, and Glial-Derived Neurotrophic Factor&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-nurrl-gene">Vitamin D and the Nurrl Gene&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pd-and-vitamin-d-evidence-against-a-relationship-less-pd-with-darker-skin">PD and Vitamin D: Evidence Against a Relationship (less PD with darker skin)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#meta-analysis">Meta-analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-pd-biological-evidence-for-and-against">Vitamin D and PD: Biological Evidence for and Against&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#clinical-trials">Clinical Trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#epidemiological-studies-present">Epidemiological Studies Present&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#proposed-novel-experimental-paradigms">Proposed Novel Experimental Paradigms&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-trials-1">Clinical Trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h1 id="parkinsons-disease-and-the-sunshine-vitamin---july-2013">Parkinson’s Disease and the “Sunshine” Vitamin - July 2013&lt;/h1>
&lt;p>Alzheimers Dis Parkinsonism 3:120. &lt;a href="https://doi.org/10.4172/2161-0460.1000120">doi: 10.4172/2161-0460.1000120&lt;/a>&lt;/p></description></item><item><title>Parkinson's Disease perhaps prevented and treated by Vitamin D</title><link>/posts/parkinsons-disease-perhaps-prevented-and-treated-by-vitamin-d.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-perhaps-prevented-and-treated-by-vitamin-d.html</guid><description>&lt;h2 id="parkinsons-disease-and-the-sunshine-vitamin">Parkinson&amp;rsquo;s Disease and the &amp;ldquo;Sunshine&amp;rdquo; Vitamin&lt;/h2>
&lt;p>Alzheimers Dis Parkinsonism 2013, 3:2 &lt;a href="http://dx.doi.org/10.4172/2161-0460.1000120">http://dx.doi.org/10.4172/2161-0460.1000120&lt;/a>&lt;/p>
&lt;p>Lucy Elisabeth James1 and Ayodeji A Asuni2 &lt;a href="mailto:a.a.asuni@soton.ac.uk">a.a.asuni@soton.ac.uk&lt;/a>&lt;/p>
&lt;p>1 Biomedical Sciences Undergraduate Program, Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom&lt;/p>
&lt;p>2 Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom&lt;/p>
&lt;p>Accrued evidence suggesting that hypovitaminosis D acts as a risk factor for developing Parkinson&amp;rsquo;s disease (PD) remains controversial. Herein we evaluated existing results, and outline several biological mechanisms by which the hypovitaminosis D-PD relationship may occur. We performed a meta-analysis, using data obtained from a search of PubMed from July 2002 to July 2012, for studies reporting serum vitamin D levels in PD and control patients.We found that in comparison to healthy individuals, those with PD had lower levels of serum vitamin D. Furthermore, we explore a number of potential associated biological mechanisms, including the actions of reactive nitrogen species (RNS), glutathione (GSH), and glial-derived neurotrophic factor (GDNF) in the brain. We also examine the roles of Nurrl and VDR genes in PD. Although a unifying hypothesis remains challenging, there is evidence to demonstrate that supplementation with the vitamin can to have a positive effect on PD pathobiology. We surmise that hypovitaminosis D does act as a risk factor in the development of PD. However, the need for new epidemiological studies and further research around vitamin D metabolism is highlighted. Urgent efforts to correct vitamin D deficiency through supplementation are warranted as they may improve either motor and/or non-motor symptoms in PD.&lt;/p></description></item><item><title>Parkinson's disease might be prevented and treated with vitamin D (tiny abstract)</title><link>/posts/parkinsons-disease-might-be-prevented-and-treated-with-vitamin-d-tiny-abstract.html</link><pubDate>Tue, 29 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-might-be-prevented-and-treated-with-vitamin-d-tiny-abstract.html</guid><description>&lt;h3 id="vitamin-d-preventive-and-therapeutic-potential-in-parkinsons-disease">Vitamin D: Preventive and Therapeutic Potential in Parkinson&amp;rsquo;s disease&lt;/h3>
&lt;p>Curr Drug Metab. 2013 Nov;14(9):989-93.&lt;/p>
&lt;p>Liu Y, Li YW, Tang YL, Liu X, Jiang JH, Li QG, Yuan JY.&lt;/p>
&lt;p>Division of Clinical Pharmacy, School of Pharmacy, Chongqing Medical University, China. &lt;a href="mailto:liuyanpharm@vip.qq.com">liuyanpharm@vip.qq.com&lt;/a>.&lt;/p>
&lt;p>Vitamin D is one of the important nuclear steroid transcription regulators that controls transcriptions of a large number of genes.&lt;/p>
&lt;p>Vitamin D supplement is commonly recommended for the elderly to prevent bone diseases.&lt;/p></description></item><item><title>Parkinson's Disease poor verbal fluency and memory strongly associated with low vitamin D</title><link>/posts/parkinsons-disease-poor-verbal-fluency-and-memory-strongly-associated-with-low-vitamin-d.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-poor-verbal-fluency-and-memory-strongly-associated-with-low-vitamin-d.html</guid><description>&lt;h3 id="memory-mood-and-vitamin-d-in-persons-with-parkinsons-disease">Memory, Mood, and Vitamin D in Persons with Parkinson&amp;rsquo;s Disease.&lt;/h3>
&lt;p>J Parkinsons Dis. 2013 Sep 30.&lt;/p>
&lt;p>Peterson AL, Murchison C, Zabetian C, Leverenz J, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF.&lt;/p>
&lt;p>Portland, OR, USA Oregon Health and Sciences University.&lt;/p>
&lt;p>Background: Research in recent years has suggested a role of vitamin D in the central nervous system. The final converting enzyme and the vitamin D receptor are found throughout the human brain. From animal studies vitamin D appears important in neurodevelopment, up-regulation of neurotrophic factors, stabilization of mitochondrial function, and antioxidation.&lt;/p></description></item><item><title>Milk casein may be an additional factor in Parkinson's disease</title><link>/posts/milk-casein-may-be-an-additional-factor-in-parkinsons-disease.html</link><pubDate>Sun, 22 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/milk-casein-may-be-an-additional-factor-in-parkinsons-disease.html</guid><description>&lt;h4 id="the-role-of-milk-protein-in-increasing-risk-of-parkinsons-disease">The role of milk protein in increasing risk of Parkinson&amp;rsquo;s disease&lt;/h4>
&lt;p>Eur J Epidemiol. 2013 Apr;28(4):357. &lt;a href="https://doi.org/10.1007/s10654-013-9786-y.">doi: 10.1007/s10654-013-9786-y.&lt;/a> Epub 2013 Feb 21.&lt;/p>
&lt;p>Grant WB. Comment on Dietary and lifestyle variables in relation to incidence of Parkinson&amp;rsquo;s disease in Greece. &lt;span>[Eur J Epidemiol. 2013]&lt;/span>&lt;/p>
&lt;p>PMID: 23430036&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="dietary-and-lifestyle-variables-in-relation-to-incidence-of-parkinsons-disease-in-greece">Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece&lt;/h4>
&lt;p>European Journal of Epidemiology; January 2013, Volume 28, Issue 1, pp 67-77&lt;/p></description></item><item><title>Parkinson’s 26 percent less likely if person worked outdoors all of the time</title><link>/posts/parkinsons-26-percent-less-likely-if-person-worked-outdoors-all-of-the-time.html</link><pubDate>Sun, 15 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-26-percent-less-likely-if-person-worked-outdoors-all-of-the-time.html</guid><description>&lt;h1 id="parkinsons-disease-and-history-of-outdoor-occupation">Parkinson&amp;rsquo;s disease and history of outdoor occupation&lt;/h1>
&lt;p>Parkinsonism &amp;amp; Related Disorders&lt;/p>
&lt;p>Elena Kwona, Lisa G. Gallagherb, Susan Searles Nielsenb, Gary M. Franklinb, Christopher T. Littella, W.T. Longstreth Jr.c, d, Phillip D. Swansonc, Harvey Checkowayb, d, &lt;a href="mailto:checko@u.washington.edu">checko@u.washington.edu&lt;/a>&lt;/p>
&lt;p>a United States Army, Madigan Army Medical Center, Department of Preventive Medicine, United States&lt;/p>
&lt;p>b University of Washington, Department of Environmental and Occupational Health Sciences, Seattle, WA, United States&lt;/p>
&lt;p>c University of Washington, Department of Neurology, Seattle, WA, United States&lt;/p></description></item><item><title>Vitamin D and MS, ALS, Autism, Alzheimer’s and other nervous system diseases – review</title><link>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</link><pubDate>Sat, 13 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</guid><description>&lt;h2 id="review-the-role-of-vitamin-d-in-nervous-system-health-and-disease">Review: The role of vitamin D in nervous system health and disease&lt;/h2>
&lt;p>Neuropathology and Applied Neurobiology. Volume 39, Issue 5, pages 458–484, August 2013&lt;/p>
&lt;p>G. C. DeLuca 1,gabriele.deluca@ndcn.ox.ac.uk&lt;/p>
&lt;p>S. M. Kimball 3,&lt;/p>
&lt;p>J. Kolasinski 1,&lt;/p>
&lt;p>S. V. Ramagopalan 2,&lt;/p>
&lt;p>G. C. Ebers 1&lt;/p>
&lt;p>1 Nuffield Department of Clinical Neurosciences (Clinical Neurology), University of Oxford, Oxford&lt;/p>
&lt;p>2 Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK&lt;/p></description></item><item><title>Alzheimer’s and Parkinson’s diseases associated with low vitamin D – meta-analysis</title><link>/posts/alzheimers-and-parkinsons-diseases-associated-with-low-vitamin-d-meta-analysis.html</link><pubDate>Wed, 22 May 2013 00:00:00 +0000</pubDate><guid>/posts/alzheimers-and-parkinsons-diseases-associated-with-low-vitamin-d-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-levels-in-alzheimers-and-parkinsons-diseases-a-meta-analysis">Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-levels-in-alzheimers-and-parkinsons-diseases-a-meta-analysis">Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis&lt;/h2>
&lt;p>Nutrition, Volume 29, Issue 6 , Pages 828-832, June 2013&lt;/p>
&lt;p>Yan Zhao, B.Sc., Yan Sun, B.Sc., Hong-Fang Ji, Ph.D. &lt;a href="mailto:jhf@sdut.edu.cn">jhf@sdut.edu.cn&lt;/a>, Liang Shen, Ph.D.email address&lt;/p>
&lt;p>Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Shandong University of Technology, Zibo, P. R. China&lt;/p>
&lt;p>Received 6 July 2012; accepted 25 November 2012. published online 15 February 2013.&lt;/p></description></item><item><title>Parkinson's disease stabilized with just 1200 IU of vitamin D – RCT</title><link>/posts/parkinsons-disease-stabilized-with-just-1200-iu-of-vitamin-d-rct.html</link><pubDate>Thu, 14 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-stabilized-with-just-1200-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="randomized-double-blind-placebo-controlled-trial-of-vitamin-d-supplement-in-parkinsons-disease">Randomized, double-blind, placebo-controlled trial of vitamin D supplement in Parkinson&amp;rsquo;s disease&lt;/h4>
&lt;p>Am J Clin Nutr May 2013 ajcn.051664&lt;/p>
&lt;p>Masahiko Suzuki, Masayuki Yoshioka, Masaya Hashimoto, Maiko Murakami, Miki Noya, Daisuke Takahashi, and Mitsuyoshi Urashima; &lt;a href="mailto:urashima@jikei.ac.jp">urashima@jikei.ac.jp&lt;/a>&lt;/p>
&lt;p>1 From the Department of Neurology, Katsushika Medical Center (MS, MY, MH, MM, and MN) and the Division of Molecular Epidemiology (MN, DT, and MU), Jikei University School of Medicine, Tokyo, Japan.&lt;/p>
&lt;p>&lt;strong>Author Notes&lt;/strong>&lt;/p>
&lt;p>↵2 Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.&lt;/p></description></item><item><title>20 percent less chance of Parkinson’s disease if work outdoors some – Thesis</title><link>/posts/20-percent-less-chance-of-parkinsons-disease-if-work-outdoors-some-thesis.html</link><pubDate>Sat, 02 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/20-percent-less-chance-of-parkinsons-disease-if-work-outdoors-some-thesis.html</guid><description>&lt;h2 id="outdoor-occupational-history-and-risk-of-parkinson-disease-a-case-control-study">Outdoor Occupational History and Risk of Parkinson Disease: a Case-Control Study&lt;/h2>
&lt;p>Kwon, Elena Hindh Noor&lt;/p>
&lt;p>Introduction: A role for antioxidants in prevention of Parkinson disease has been proposed, however, epidemiologic evidence supporting this assertion has been inconclusive. Ninety percent of vitamin D in adults is produced in vivo related to ultraviolet type B exposure. This creates a plausible role for outdoor work as a strong surrogate for vitamin D in studies related to neurodegenerative disease.&lt;/p></description></item><item><title>Hip fractures greatly reduced by sunshine, vitamin D, and vitamin K – meta-analysis</title><link>/posts/hip-fractures-greatly-reduced-by-sunshine-vitamin-d-and-vitamin-k-meta-analysis.html</link><pubDate>Fri, 23 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hip-fractures-greatly-reduced-by-sunshine-vitamin-d-and-vitamin-k-meta-analysis.html</guid><description>&lt;h4 id="strategy-for-prevention-of-hip-fractures-in-patients-with-parkinsons-disease">Strategy for prevention of hip fractures in patients with Parkinson&amp;rsquo;s disease.&lt;/h4>
&lt;p>World J Orthop. 2012 Sep 18;3(9):137-41. &lt;a href="https://doi.org/10.5312/wjo.v3.i9.137.">doi: 10.5312/wjo.v3.i9.137.&lt;/a>&lt;/p>
&lt;p>Iwamoto J, Sato Y, Takeda T, Matsumoto H.&lt;/p>
&lt;p>Jun Iwamoto, Tsuyoshi Takeda, Hideo Matsumoto, Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.&lt;/p>
&lt;p>Hypovitaminosis D and K due to malnutrition or sunlight deprivation, increased bone resorption due to immobilization, low bone mineral density (BMD) and an increased risk of falls may contribute to an increased risk of hip fractures in patients with Parkinson&amp;rsquo;s disease. The purpose of the present study was to clarify the efficacy of interventions intended to prevent hip fractures in elderly patients with Parkinson&amp;rsquo;s disease. PubMed was used to search the literature for randomized controlled trials (RCTs) regarding Parkinson&amp;rsquo;s disease and hip fractures. The inclusion criteria were 50 or more subjects per group and a study period of 1 year or longer.&lt;/p></description></item><item><title>Review of Parkinson's disease and vitamin D recommends use of active form</title><link>/posts/review-of-parkinsons-disease-and-vitamin-d-recommends-use-of-active-form.html</link><pubDate>Wed, 29 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-parkinsons-disease-and-vitamin-d-recommends-use-of-active-form.html</guid><description>&lt;h1 id="vitamin-d-and-parkinsons-disease">Vitamin D and Parkinson&amp;rsquo;s disease&lt;/h1>
&lt;p>Journal of Neuroscience Research, 28 AUG 2012&lt;/p>
&lt;p>Khanh vinh quôc Luong*, Lan Thi Hoàng Nguyên&lt;/p>
&lt;p>Parkinson&amp;rsquo;s disease (PD) is the second most common form of neurodegeneration among the elderly population.&lt;/p>
&lt;p>PD is clinically characterized by&lt;/p>
&lt;ul>
&lt;li>
&lt;p>tremors,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>rigidity,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>slowness of movement, and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>postural imbalance.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>Interestingly, a significant association has been demonstrated between PD and low levels of vitamin D in the serum, and vitamin D supplement appears to have a beneficial clinical effect on PD.&lt;/p></description></item><item><title>Role of vitamin D in Parkinson's disease</title><link>/posts/role-of-vitamin-d-in-parkinsons-disease.html</link><pubDate>Sun, 03 Jun 2012 00:00:00 +0000</pubDate><guid>/posts/role-of-vitamin-d-in-parkinsons-disease.html</guid><description>&lt;p>ISRN Neurol. 2012;2012:134289. Epub 2012 Mar 7.&lt;/p>
&lt;p>L Ng K, Nguy?n L.&lt;/p>
&lt;p>Vietnamese American Medical Research Foundation, Westminster, CA 92683, USA.&lt;/p>
&lt;p>Parkinson&amp;rsquo;s disease (PD) is the second most common form of neurodegeneration in the elderly population. Clinically, it is characterized by tremor, rigidity, slowness of movement, and postural imbalance. A significant association between low serum vitamin D and PD has been demonstrated, suggesting that elevated vitamin D levels might provide protection against PD. Genetic studies have helped identify a number of proteins linking vitamin D to PD pathology, including the major histocompatibility complex (MHC) class II, the vitamin D receptor (VDR), cytochrome P450 2D6 (CYP2D6), chromosome 22, the renin-angiotensin system (RAS), heme oxygenase-1 (HO-1), poly(ADP-ribose) polymerase-1 gene (PARP-1), neurotrophic factor (NTF), and Sp1 transcription factor. Vitamin D has also been implicated in PD through its effects on L-type voltage-sensitive calcium channels (L-VSCC), nerve growth factor (NGF), matrix metalloproteinases (MMPs), prostaglandins (PGs) and cyclooxygenase-2 (COX-2), reactive oxygen species (ROS), and nitric oxide synthase (NOS).&lt;/p></description></item><item><title>5X fewer hip fractures from Parkinson – Alzheimer – Stroke with enough sun</title><link>/posts/5x-fewer-hip-fractures-from-parkinson-alzheimer-stroke-with-enough-sun.html</link><pubDate>Wed, 22 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/5x-fewer-hip-fractures-from-parkinson-alzheimer-stroke-with-enough-sun.html</guid><description>&lt;h4 id="sunlight-exposure-is-important-for-preventing-hip-fractures-in-patients-with-alzheimers-disease-parkinsons-disease-or-stroke">Sunlight exposure is important for preventing hip fractures in patients with Alzheimer’s disease, Parkinson’s disease, or stroke&lt;/h4>
&lt;p>Acta Neurologica Scandinavica, Article first published online: 18 JUN 2011; DOI: 10.1111/j.1600-0404.2011.01555.x&lt;/p>
&lt;p>J. Iwamoto, T. Takeda, H. Matsumoto&lt;/p>
&lt;p>Objectives?–? Hypovitaminosis D as a result of malnutrition or sunlight deprivation, increased bone resorption, low bone mineral density (BMD), or an increased risk of falls may contribute to an increased risk of hip fractures in patients with neurological diseases, including Alzheimer’s disease, Parkinson’s disease, and stroke. The purpose of this study was to clarify the efficacy of sunlight exposure for reducing the risk of hip fractures in patients with such neurological diseases.&lt;/p></description></item><item><title>Parkinson disease increased in Israel by 50 percent in 7 years</title><link>/posts/parkinson-disease-increased-in-israel-by-50-percent-in-7-years.html</link><pubDate>Thu, 09 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/parkinson-disease-increased-in-israel-by-50-percent-in-7-years.html</guid><description>&lt;h1 id="new-method-for-measuring-parkinsons-disease-prevalence-reveals-sharp-increase-in-israel">New method for measuring Parkinson&amp;rsquo;s disease prevalence reveals sharp increase in Israel&lt;/h1>
&lt;p>&lt;a href="http://medicalxpress.com/news/2011-06-method-parkinson-disease-prevalence-reveals.html%20">June 9, 2011 Medical Xpress&lt;/a>&lt;/p>
&lt;p>In a new study published today in the inaugural issue of the Journal of Parkinson&amp;rsquo;s Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson&amp;rsquo;s disease (PD) cases in a large population. The study identified a sharp rise in PD prevalence from 170/100,000 in 2000 to 256/100,000 in 2007 in Israel, which warrants further investigation.&lt;/p></description></item><item><title>9 minutes a day of sun improved BMD Parkinsons disease patients</title><link>/posts/9-minutes-a-day-of-sun-improved-bmd-parkinsons-disease-patients.html</link><pubDate>Sat, 14 May 2011 00:00:00 +0000</pubDate><guid>/posts/9-minutes-a-day-of-sun-improved-bmd-parkinsons-disease-patients.html</guid><description>&lt;h1 id="amelioration-of-osteoporosis-and-hypovitaminosis-d-by-sunlight-exposure-in-parkinsons-disease">Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson&amp;rsquo;s disease.&lt;/h1>
&lt;p>Parkinsonism Relat Disord. 2011 Jan;17(1):22-6. Epub 2010 Nov 2.&lt;/p>
&lt;p>Sato Y, Iwamoto J, Honda Y.&lt;/p>
&lt;p>Department of Neurology, Mitate Hospital, 3237 Yugeta, Tagawa 826-0041, Japan. &lt;a href="mailto:y-sato@ktarn.or.jp">y-sato@ktarn.or.jp&lt;/a>&lt;/p>
&lt;p>A high incidence of fractures, particularly of the hip, represents an important problem in patients with Parkinson&amp;rsquo;s disease (PD), who are prone to falls and have osteoporosis. We previously showed that 25-hydroxyvitamin D (25-OHD) deficiency due to sunlight deprivation with compensatory hyperparathyroidism causes reduced bone mineral density (BMD) in elderly patients with PD. The present study was undertaken to address the possibility that sunlight exposure may maintain BMD and reduce the incidence of hip fracture in elderly patients with PD. In a prospective study, PD patients were assigned to regular sunlight exposure (n=162) or usual lifestyle (n=162), and followed for 2 years. BMD of the second metacarpal bone was measured using a computed X-ray densitometer. Incidence of hip fracture in the two patient groups during the 2 year follow-up period was assessed. At baseline, patients of both groups showed vitamin D deficiency due to sunlight deprivation with compensatory hyperparathyroidism. The exposed group patients were exposed to sunlight (3231 min/year).&lt;/p></description></item><item><title>Vitamin D levels were low at start of Parkinson Disease – but did not drop lower</title><link>/posts/vitamin-d-levels-were-low-at-start-of-parkinson-disease-but-did-not-drop-lower.html</link><pubDate>Thu, 12 May 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-were-low-at-start-of-parkinson-disease-but-did-not-drop-lower.html</guid><description>&lt;h1 id="low-vitamin-d-levels-may-precede-parkinsons-symptoms">Low Vitamin D Levels May Precede Parkinson’s Symptoms&lt;/h1>
&lt;p>&lt;a href="http://www.pdf.org/en/science_news/release/pr_1302025378">Parkinson’s Disease Foundation&lt;/a> - Apr 05 2011&lt;/p>
&lt;p>People with a recent diagnosis of Parkinson’s disease (PD) were found to have low blood levels of vitamin D in a study published in the March 2011 issue of Neurology. The study authors suggest that people with PD may not have been getting enough vitamin D for a long time before Parkinson’s symptoms developed, and that vitamin D deficiency may play a role in causing the disease.&lt;/p></description></item><item><title>Reduced vitamin D and BMD and Neurological Conditions</title><link>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</link><pubDate>Wed, 04 May 2011 00:00:00 +0000</pubDate><guid>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</guid><description>&lt;h1 id="bone-mineral-density-in-adults-disabled-through-acquired-neurological-conditions-a-review">Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/h1>
&lt;p>Journal of Clinical Densitometry&lt;/p>
&lt;p>Volume 14, Issue 2 , Pages 85-94, April 2011&lt;/p>
&lt;p>Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/p>
&lt;p>Áine Carroll&lt;/p>
&lt;p>Received 10 June 2010; received in revised form 12 December 2010; accepted 13 December 2010. published online 07 April 2011.&lt;/p>
&lt;p>This article is a review of the changes in bone mineral density (BMD), which occur in a number of acquired neurological conditions resulting in disability.&lt;/p></description></item><item><title>3 instead of 11 fractures with Parkinson disease when have enough sun</title><link>/posts/3-instead-of-11-fractures-with-parkinson-disease-when-have-enough-sun.html</link><pubDate>Sat, 06 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/3-instead-of-11-fractures-with-parkinson-disease-when-have-enough-sun.html</guid><description/></item><item><title>Outdoor trades much less likely to get Parkinson disease</title><link>/posts/outdoor-trades-much-less-likely-to-get-parkinson-disease.html</link><pubDate>Tue, 05 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/outdoor-trades-much-less-likely-to-get-parkinson-disease.html</guid><description>&lt;h3 id="outdoor-work-and-risk-for-parkinsons-disease-a-population-based-casecontrol-study">Outdoor work and risk for Parkinson&amp;rsquo;s disease: a population-based case–control study&lt;/h3>
&lt;p>Occup Environ Med doi:10.1136/oem.2010.057448&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Line Kenborg1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Christina F Lassen1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Beate Ritz2,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Eva S Schernhammer3,4,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Johnni Hansen1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Nicole M Gatto5,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Jørgen H Olsen1&lt;/p>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> 1Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> 2Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, California, USA
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> 3Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> 4Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> 5Department of Epidemiology, School of Public Health, University of California, Los Angeles, California, USA
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;p>Correspondence to Line Kenborg, Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen, Denmark; &lt;a href="mailto:kenborg@cancer.dk">kenborg@cancer.dk&lt;/a>&lt;/p></description></item><item><title>Low Vitamin D increases Parkinson by 3X</title><link>/posts/low-vitamin-d-increases-parkinson-by-3x.html</link><pubDate>Wed, 25 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-increases-parkinson-by-3x.html</guid><description>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pd-risk.jpg" alt="image">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/risk-of-pd---2010.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;a href="https://scholar.google.com/scholar?cites=14098833721532676136&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">Google Scholar&lt;/a> 303 references as of Oct 2022&lt;/p>
&lt;hr>
&lt;p>July 13 2010 NHS (UK)&lt;/p>
&lt;p>&lt;a href="http://www.nhs.uk/news/2010/july07/pages/vitamin-d-parkinsons-disease.aspx">http://www.nhs.uk/news/2010/july07/pages/vitamin-d-parkinsons-disease.aspx&lt;/a>&lt;/p>
&lt;p>Parkinson&amp;rsquo;s disease is caused by a lack of dopamine in the brain&lt;/p>
&lt;p>“Low vitamin D levels may increase a person&amp;rsquo;s risk of developing Parkinson&amp;rsquo;s disease,” BBC News has reported. Its website said that people with the &lt;strong>lowest levels of vitamin D had a three-fold higher risk of developing Parkinson’s disease.&lt;/strong>&lt;/p></description></item><item><title>Appears that some CNS ageing problems can be avoided with vitamin D</title><link>/posts/appears-that-some-cns-ageing-problems-can-be-avoided-with-vitamin-d.html</link><pubDate>Wed, 11 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/appears-that-some-cns-ageing-problems-can-be-avoided-with-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-and-ageing-neurological-issues">Vitamin D and Ageing: Neurological Issues.&lt;/h1>
&lt;p>Neuropsychobiology. 2010;62(3):139-150. Epub 2010 Jul 14.&lt;/p>
&lt;p>Annweiler C, Schott AM, Berrut G, Chauviré V, Le Gall D, Inzitari M, Beauchet O.&lt;/p>
&lt;p>Angers University Memory Center, Angers, France.&lt;/p>
&lt;p>Objective: Vitamin D has been shown to have multiple biological targets mediated by the vitamin D receptor present in many cells. Specific actions on the central nervous system (CNS) have been described. The objective of this review was to describe the relationship between vitamin D and the nervous system throughout the different stages of life.&lt;/p></description></item><item><title>Overview Alzheimer's-Cognition and Vitamin D</title><link>/posts/overview-alzheimers-cognition-and-vitamin-d.html</link><pubDate>Tue, 06 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/overview-alzheimers-cognition-and-vitamin-d.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;ul>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> Cognitive decline is &lt;a href="/tags/19x-more-likely.html">19X more likely&lt;/a> if low vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> Dementia is associated with low vitamin D levels.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> &lt;a href="/posts/alzheimers-dementia-23x-more-likely-in-elderly-if-low-vitamin-d">Alzheimer’s Dementia 2.3X more likely in elderly if low vitamin D – Dec 2022&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> &lt;a href="/posts/dementia-is-associated-with-low-vitamin-d-many-studies">Dementia is associated with low vitamin D - many studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> &lt;strong>&lt;span style="color:#900;">Alzheimer&amp;rsquo;s &lt;/span>&lt;/strong> Disease is &lt;a href="/tags/span-stylecolor900span-span-stylecolor00f4xspan-less-likely-if-high-vitamin-d.html"> &lt;strong>&lt;span style="color:#900;">&lt;/span>&lt;/strong> &lt;strong>&lt;span style="color:#00F;">4X&lt;/span>&lt;/strong> less likely if high vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>FACT:&lt;/strong> Every single risk factor listed for &lt;strong>&lt;span style="color:#900;">Alzheimer&amp;rsquo;s &lt;/span>&lt;/strong> Disease is also a risk factor for low vitamin D levels&lt;/p></description></item><item><title>Overview Parkinson's and Vitamin D</title><link>/posts/overview-parkinsons-and-vitamin-d.html</link><pubDate>Mon, 28 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/overview-parkinsons-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#see-also-on-vitamindwiki">See also on VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#those-with-pd-have-7x-higherlower-amounts-of-certain-gut-bacteria---jan-2023">Those with PD have 7X higher/lower amounts of certain gut bacteria - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#candidate-nutraceuticals-to-fight-pd-oct-2022">Candidate nutraceuticals to fight PD (Oct 2022)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#parkinsons-incidence-increase-10-x-in-60-years">Parkinson&amp;rsquo;s incidence increase 10 X in 60 years&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-on-web">See also on web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-induced-vertebral-fractures-may-cause-span-stylecolorf00stooped-posturespan-in-parkinson-disease---2011">Vitamin D Deficiency-Induced Vertebral Fractures May Cause &lt;span style="color:#F00;">Stooped Posture&lt;/span> in Parkinson Disease - 2011&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#age-adjusted-death-from-parkinsons">Age-Adjusted death from Parkinson&amp;rsquo;s&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#high-prevalence-of-hypovitaminosis-d-status-in-patients-with-early-parkinson-disease">High prevalence of hypovitaminosis D status in patients with early Parkinson disease.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#remember-vitamin-d-to-forget-parkinsons-diseasehttpwwwknowabouthealthcomremember-vitamin-d-to-forget-parkinsons-disease4140-july-2012">&lt;a href="http://www.knowabouthealth.com/remember-vitamin-d-to-forget-parkinsons-disease/4140/">Remember Vitamin D to forget Parkinson’s disease&lt;/a> July 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#parkinsons-may-be-an-autoimmune-disease-data-since-2017">Parkinson&amp;rsquo;s may be an Autoimmune Disease (data since 2017)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-is-parkinsons-from-mj-foxhttpswwwmichaeljfoxorg">What is Parkinson&amp;rsquo;s (From &lt;a href="https://www.michaeljfox.org/">MJ Fox&lt;/a>)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#emerging-role-of-nutrition-in-pd---vitamin-d-and-omega-3-are-mentioned---2014">Emerging role of Nutrition in PD - vitamin D and Omega-3 are mentioned - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#risk-of-dementia-reduced-50-by-just-using-brain-plasticity-software-for-just-13-hours---nov-2017">Risk of Dementia reduced 50% by just using Brain Plasticity Software for just 13 hours - Nov 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-rehabilitation-better-with-virtual-reality---review-april-2021">PD rehabilitation better with Virtual Reality - Review April 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#excess-manganese-increases-the-risk-of-parkinsons-symptoms-first-described-in-1837">Excess Manganese increases the Risk of Parkinson&amp;rsquo;s Symptoms (first described in 1837)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#trichloroethylene-increases-the-risk-of-pd-by-5x---nov-2023">Trichloroethylene increases the risk of PD by 5X - Nov 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-associated-with--α-synuclein-from-colon-via-vagus-nerve-due-to-more-meat-and-less-fiber---dr-greger-sept-2021">PD associated with α-synuclein from colon via vagus nerve, due to more meat and less fiber - Dr. Greger Sept 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#end-of-alzheimers-protocol-can-be-applied-to-parkinsons-too">&amp;ldquo;End of Alzheimers&amp;rdquo; protocol can be applied to Parkinson&amp;rsquo;s too&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#parkinsons-death-rate-increased-63-from-1999---2019">Parkinson&amp;rsquo;s death rate increased 63% from 1999 - 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-viral-infections-increase-the-risk-of-parkinsons-years-later">Some Viral infections increase the risk of Parkinson&amp;rsquo;s years later&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#us-parkinsons-disease-90000-new-cases-each-year---dec-2022">US Parkinson&amp;rsquo;s Disease: 90,000 new cases each year - Dec 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-problems-reduced-by-vitamin-b12">PD problems reduced by Vitamin B12&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#taichi---12-weeks-online-reduced-pd-gate-and-posture-problems----sept-2023">TaiChi - 12 weeks online, reduced PD gate and posture problems - Sept 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#microplastics-might-be-a-cause-of-parkinsons---nov-2023">Microplastics might be a cause of Parkinson&amp;rsquo;s - Nov 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#poor-gut-bacteria--parkinsons---jan-2024">Poor gut bacteria ==&amp;gt; Parkinson&amp;rsquo;s? - Jan 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="see-also-on-vitamindwiki">See also on VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/parkinsons-disease-and-vitamin-d-review-finds-promising-indications">Parkinson&amp;rsquo;s disease and vitamin D – review finds promising indications – April 2014&lt;/a>&lt;/p></description></item></channel></rss>